Drugs for Kidney Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 845)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Acarbose |
Approved, Investigational |
Phase 4 |
|
56180-94-0 |
441184 |
Synonyms:
(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
(3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
1,4-DEOXY-4-((5-HYDROXYMETHYL-2,3,4-TRIHYDROXYCYCLOHEX-5,6-ENYL)AMINO)FRUCTOSE
1agm
1gah
1k1y
1lf9
1ukt
4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucopyranose
4,6-dideoxy-4-{[(1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucose
56180-94-0
AC1L26GM
AC1L9APL
AC1L9G0J
AC1L9HYX
AC1NAU1X
AC1OCEJZ
Acarbosa
Acarbosa [INN-Spanish]
acarbose
Acarbose
Acarbose (JAN/USAN/INN)
Acarbose [USAN:BAN:INN:JAN]
Acarbosum
Acarbosum [INN-Latin]
ACI-(1-4)GLD-(1-4)GLC-(1-4)GLB
ACR
Alpha-Acarbose
Bay g 5421
Bayer brand OF acarbose
BAY-g 5421
Bay-g-5421
BB_NC-1311
Beta-Acarbose
C06802
C25H43NO18
CHEBI:2376
CHEBI:506767
CHEMBL1566
CHEMBL394434
|
CHEMBL569486
CID10627975
CID41774
CID441184
CID4432690
CID444254
CID445421
CPD000466376
D00216
DB00284
EINECS 260-030-7
Glucobay
Glucor
Glumida
HMC-(1-4)AGL-(1-4)GLC-(1-4)GLC
HMS2051F03
HMS2093I22
Lasa brand OF acarbose
LS-71702
MLS000759506
MLS001424056
MolPort-002-507-369
MolPort-003-844-373
NCGC00096061-01
NCGC00096061-02
NCGC00160515-01
O-4,6-Dideoxy-4-(((1S-(1alpha,4alpha,5beta,6alpha))-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-D-glucose
O-4,6-Dideoxy-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1->4)-O-alpha-D-glucopyranosyl-(1->4)-D-glucose
O-4,6-Dideoxy-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1-4)-O-alpha-D-glucopyranosyl-(1-4)-D-glucose
Prandase
Prandase, Precose, Glucobay, Bay-g 5421, Acarbose
Precose
Precose (TN)
QPS
S1271_Selleck
SAM001246733
SMR000466376
SPECTRUM1505172
STK801930
UNII-T58MSI464G
|
|
2 |
|
Hydralazine |
Approved |
Phase 4 |
|
86-54-4 |
3637 |
Synonyms:
(1Z)-1(2H)-Phthalazinone hydrazone
(2H)-Phthalazinone hydrazone
[2H-Phthalazin-(1Z)-Ylidene]-Hydrazine Hydrochloride
1(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone, hydrazone
1-Hydrazinophthalazine
1-Phthalazinylhydrazine
304-20-1 (mono-hydrochloride)
5-25-17-00412 (Beilstein Handbook Reference)
6-Hydralazine
86-54-4
AC1L1GDN
AC1Q4UY1
AKOS000122609
Apresolin
Apresoline
Apressin
Apressin (pharmaceutical)
Apressoline
Aprezolin
BA 5968
BRD-K82103381-003-03-7
BRN 0132615
BSPBio_002130
C 5968
C07040
C-5068
C-5968
C8H8N4
CAS-304-20-1
CCRIS 5385
CHEBI:5775
CHEMBL276832
Ciba 5968
CID3637
D08044
DB01275
DivK1c_000117
EC-000.1838
EINECS 201-680-3
Hidral
Hidral (TN)
Hidralazin
Hidralazina
Hidralazina [INN-Spanish]
Hidralazina [Spanish]
Hipoftalin
HLZ
Hydralazin
hydralazine
Hydralazine
Hydralazine (INN)
Hydralazine [INN:BAN]
Hydralazine hydrochloride
Hydralazine mono hydrochloride
|
Hydralazine mono-hydrochloride
Hydralazinum
Hydralazinum [INN-Latin]
Hydrallazin
Hydrallazine
Hydrazinophthalazine
Hydrazone 1(2H)-phthalazinone
Hydrochloride, hydralazine
Hypophthalin
IDI1_000117
Idralazina
Idralazina [DCIT]
Idralazina [Italian]
InChI=1/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)
KBio1_000117
KBio2_001355
KBio2_003923
KBio2_006491
KBio3_001350
KBioGR_000349
KBioSS_001355
Lopac0_000593
Lopac-H-1753
LS-109171
MolPort-000-876-738
MolPort-001-794-088
mono-Hydrochloride, hydralazine
NCGC00015501-01
NCGC00015501-02
NCGC00015501-05
NCGC00162199-01
NCIOpen2_001484
Nepresol
NINDS_000117
NSC 126699
NSC126699
Oprea1_207681
Oprea1_416878
phthalazin-1-ylhydrazine
Phthalazin-1-ylhydrazine
Praparat 5968
Prestwick0_000169
Prestwick1_000169
Prestwick2_000169
SPBio_000977
SPBio_001958
Spectrum_000875
Spectrum2_000969
Spectrum3_000455
Spectrum4_000005
Spectrum5_000822
ST50512087
UNII-26NAK24LS8
WLN: T66 CNNJ BMZ
ZINC12360535
|
|
3 |
|
Peginterferon alfa-2b |
Approved |
Phase 4 |
|
215647-85-1, 99210-65-8 |
|
Synonyms:
215647-85-1
D02748
Peginterferon alfa-2b
Peginterferon alfa-2b (generical recombination)
Peginterferon alfa-2b (generical recombination) (JAN)
|
Peginterferon alfa-2b (INN)
PegIntron
PEG-Intron
Pegintron (TN)
Unitron PEG
|
|
4 |
|
Digoxin |
Approved |
Phase 4 |
|
20830-75-5 |
30322 2724385 |
Synonyms:
(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide
0B9662A7-264E-4ACD-94B2-9E1138C0CA5A
12beta-Hydroxydigitoxin
12b-Hydroxydigitoxin
12β-hydroxydigitoxin
12Β-hydroxydigitoxin
20830-75-5
3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^
AC1MC4TN
AC1Q29PT
AWD.pharma brand OF digoxin
Bertek brand OF digoxin
BIDD:PXR0148
Boehringer, digoxina
BPBio1_000500
BRD-K23478508-001-03-7
BSPBio_000454
C06956
Cardoxin
CHEBI:4551
CHEMBL1751
CID2724385
Cogoxin
Cordioxil
D00298
D1828
D6003_FLUKA
D6003_SIGMA
D6770_SIGMA
Davoxin
Digacin
Digitalis glycoside
Digitalis Glycoside
Digitek
Digitekt
Digoregen
Digossina
digoxin
Digoxin
Digoxin (JP15/USP)
Digoxin pediatric
Digoxin Pediatric
Digoxina
Digoxina boehringer
Digoxine
Digoxine nativelle
Digoxinum
Dilanacin
Dixina
Dokim
Dynamos
Eudigox
Glaxo wellcome brand OF digoxin
GlaxoSmithKline brand 1 OF digoxin
GlaxoSmithKline brand 2 OF digoxin
|
Hemigoxine nativelle
HMS1569G16
Homolle's Digitalin
Homolle'S digitalin
Kern brand OF digoxin
Lanacordin
Lanacrist
Lanicor
Lanoxicaps
Lanoxicaps (TN)
Lanoxin
Lanoxin (TN)
Lanoxin PG
Lanoxin-PG
Lenoxicaps
Lenoxin
Lilly brand OF digoxin
Longdigox
Mapluxin
MLS000069819
MLS001055371
MLS001076495
MolPort-002-536-760
Nativelle, digoxine
Nativelle, hemigoxine
NCGC00090797-01
NCGC00090797-02
NCGC00090797-03
NCGC00090797-04
nchembio.476-comp8
Neodioxanin
Neo-lanicor
Neo-Lanicor
Novartis brand OF digoxin
Prestwick_170
Prestwick0_000437
Prestwick1_000437
Prestwick2_000437
Prestwick3_000437
Proctor and gamble brand OF digoxin
R.A.N. brand OF digoxin
Roche brand OF digoxin
Rougoxin
SK-Digoxin
SMR000059217
SMR000653537
SPBio_002393
SR-01000721866-3
ST069334
Stillacor
STOCK1N-70146
Teofarma brand OF digoxin
UDL brand OF digoxin
Vanoxin
Virco brand OF digoxin
|
|
5 |
|
Moxonidine |
Approved, Investigational |
Phase 4 |
|
75438-57-2 |
4810 |
Synonyms:
(2R,4R)-1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8- quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid
4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine
Cynt
Lilly brand OF moxonidine
Moxon
Moxonidin
Moxonidina
|
Moxonidine
Moxonidinum
Normatens
Physiotens
Solvay brand OF moxonidine
Zint
|
|
6 |
|
Zaleplon |
Approved, Illicit, Investigational |
Phase 4 |
|
151319-34-5 |
5719 |
Synonyms:
151319-34-5
3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide
3'-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide
AC1L1KZH
AC-2082
AKOS000280863
AZ-007
BIDD:GT0046
Bio-0542
C07484
C17H15N5O
CHEBI:10102
CHEMBL1521
CID5719
CL 284,846
CL 284846
CL284,846
CL-284846
CPD000238180
D00530
DB00962
DEA no. 2781
DEA No. 2781
HMS2052J11
I06-0419
L 846
L846
L-846
|
LJC 10846
LJC-10846
LS-173402
LS-8737
MLS000759451
MolPort-000-883-860
N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide
N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide
NCGC00160525-01
SAM001246641
SKP-1041
SMR000238180
Sonata
Sonata (TN)
Staccato-zaleplon
Starnoc
TL8001114
UNII-S62U433RMH
ZAL 846
ZAL-846
Zalaplon
zaleplon
Zaleplon
Zaleplon (JAN/USAN/INN)
Zaleplon [USAN:INN]
Zelepion
Zerene
ZINC00006300
|
|
7 |
|
Capsaicin |
Approved |
Phase 4 |
|
404-86-4 |
1548943 |
Synonyms:
(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide
(e)8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide
(E)-8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide(8CL)
(E)-Capsaicin
(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
[(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
12084_FLUKA
21748_FLUKA
21748_SIGMA
21750_FLUKA
21750_SIGMA
360376_ALDRICH
360376_SIGMA
404-86-4
6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl
6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI)
8 Methyl N vanillyl 6 nonenamide
8 Methyl N Vanillyl 6 Nonenamide
8-Methyl-N-vanillyl-6-nonenamide
8-Methyl-N-Vanillyl-6-Nonenamide
8-Methyl-N-vanillyl-trans-6-nonenamide
912457-62-6
AC1LU7K3
AC1Q46B3
Alacan brand OF capsaicin
Alacan Brand of Capsaicin
Antiphlogistine rub a-535 capsaicin
Antiphlogistine Rub A-535 Capsaicin
Axsain
Bio-0615
BPBio1_001053
BRD-K37056290-001-01-1
BRD-K50590187-001-06-6
BRN 2816484
BSPBio_000957
BSPBio_001548
BSPBio_002917
C06866
C-1700
C18H27NO3
Capsaicin
CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN))
Capsaicin (in oleoresin of capsicum)
Capsaicin (JAN/USP)
Capsaicin (Natural)
Capsaicin [in oleoresin of capsicum]
Capsaicin [USAN]
Capsaicin Patch
Capsaicina
Capsaicine
CAPSAICINE
Capsicum farmaya
Capsicum Farmaya
Capsidol
Capsin
Capzasin
Carter horner brand OF capsaicin
Carter Horner Brand of Capsaicin
Caswell No. 158
CCRIS 1588
Centrum brand OF capsaicin
Centrum Brand of Capsaicin
CHEBI:3374
CHEMBL294199
CID1548943
D002211
D00250
depletes Substance P
e-Capsaicin
E-CAPSAICIN
EINECS 206-969-8
Elan brand OF capsaicin
Elan Brand of Capsaicin
EPA Pesticide Chemical Code 070701
epsilon-Capsaicin
FEMA No. 3404
Flemming brand OF capsaicin
Flemming Brand of Capsaicin
FT-0082538
Gelcen
|
HMS1361N10
HMS1570P19
HMS1791N10
HMS1921H11
HMS1989N10
HMS2089N11
HMS2092D21
HMS501B16
HSDB 954
I01-2469
IDI1_000354
IDI1_034018
Isodecenoate
Isodecenoate vanillylamide
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
Link brand OF capsaicin
Link Brand of Capsaicin
LS-2138
M1149
M2028_SIGMA
Medicis brand OF capsaicin
Medicis Brand of Capsaicin
MEGxp0_001448
MLS002154049
MolPort-001-742-263
MR3H3
n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide
N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
N-[(4-hydroxy-3-methoxy-phenyl)methyl]nonanamide
NCGC00090853-01
NCGC00090853-02
NCGC00090853-03
NCGC00090853-04
NCGC00090853-06
NCGC00090853-07
NCGC00090853-08
NCGC00090853-09
nchembio.146-comp1
nchembio862-comp2
NCI-C56564
neurotoxic
NGX 4010
NGX-1998
NGX-3781
NGX4010
NGX-4010
NGX-7325
NSC 56353
NSC56353
Prestwick_204
Prestwick2_000879
Prestwick3_000879
Qutenza
S1990_Selleck
SDCCGMLS-0066678.P001
Smaller brand OF capsaicin
Smaller Brand of Capsaicin
SMP2_000337
SMR000718774
SPECTRUM1501128
Spectrum5_000538
Styptysat
Thompson brand OF capsaicin
Thompson Brand of Capsaicin
TL8002946
TQ-1018
trans-8-Methyl-N-vanillyl-6-nonenamide
Transacin
trans-Capsaicin
UNII-S07O44R1ZM
UPCMLD-DP092
UPCMLD-DP092:001
UPCMLD-DP092:002
Vinas brand OF capsaicin
Vinas Brand of Capsaicin
Zacin
ZINC01530575
Zostrix
ZOSTRIX (TN)
Zostrix HP
|
|
8 |
|
Amiodarone |
Approved, Investigational |
Phase 4 |
|
1951-25-3 |
2157 |
Synonyms:
(2-{4-[(2-butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine
(2-butyl-1-benzofuran-3-yl)(4-{[2-(diethylamino)ethyl]oxy}-3,5-diiodophenyl)methanone
(2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone
(2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone
(2-Butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diidophenyl)methanone
(2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone
1951-25-3
2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(3,5-diiodo-4-(beta-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(4'-beta-N-diethylaminoethoxy-3',5'-diiodobenzoyl)benzofuran
2-Butyl-3-[3,5-diiodo-4-(2-di
2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-((2-diethylamino)ethoxy)-m,m-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-[(2-diethylamino)ethoxy]-m,m-diiodophenyl ketone
2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
5-18-02-00353 (Beilstein Handbook Reference)
AB00053422
AC1L1D1R
AC1Q2VCU
Alphapharm brand OF amiodarone hydrochloride
Alphapharm Brand of Amiodarone Hydrochloride
Amidorone
Aminodarone
Amio-Aqueous IV
Amiobeta
Amiodarex
Amiodarona
Amiodarona [INN-Spanish]
amiodarone
Amiodarone
Amiodarone (USAN/INN)
Amiodarone [USAN:BAN:INN]
Amiodarone base
Amiodarone Base
Amiodarone HCL
Amiodarone hydrochloride
Amiodarone Hydrochloride
Amiodarons
Amiodaronum
Amiodaronum [INN-Latin]
Amiohexal
Amjodaronum
Ancar
Aratac
Armstrong brand OF amiodarone hydrochloride
Armstrong Brand of Amiodarone Hydrochloride
Arycor
ASTA medica brand OF amiodarone hydrochloride
ASTA Medica Brand of Amiodarone Hydrochloride
Berenguer infale brand OF amiodarone hydrochloride
Berenguer Infale Brand of Amiodarone Hydrochloride
Betapharm brand OF amiodarone hydrochloride
Betapharm Brand of Amiodarone Hydrochloride
BIDD:GT0425
BIDD:PXR0146
Bio1_000026
Bio1_000515
Bio1_001004
Bio2_000294
Bio2_000774
BPBio1_000372
Braxan
BRN 1271711
BSPBio_000338
BSPBio_001574
BSPBio_002580
C06823
C25H29I2NO3
CAS-19774-82-4
CBiol_001740
CHEBI:2663
CHEMBL633
CID2157
Corbionax
Cordarex
Cordarone
Cordarone Intravenous
D000638
D02910
DB01118
DivK1c_000079
EINECS 217-772-1
ethylaminoethoxy)benzoyl]benzofuran
g Gam brand OF amiodarone hydrochloride
|
G Gam Brand of Amiodarone Hydrochloride
Hexal brand OF amiodarone hydrochloride
Hexal Brand of Amiodarone Hydrochloride
HMS1791O16
HMS1989O16
HMS2089C07
Hydrochloride, amiodarone
IDI1_000079
IDI1_034044
KBio1_000079
KBio2_000294
KBio2_000741
KBio2_002862
KBio2_003309
KBio2_005430
KBio2_005877
KBio3_000587
KBio3_000588
KBio3_001800
KBioGR_000294
KBioGR_001859
KBioSS_000294
KBioSS_000741
Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl
Ketone, 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl (7CI,8CI)
Kordaron
L 3428
L001174
L3428
L-3428
Labaz
Leurquin brand OF amiodarone hydrochloride
Leurquin Brand of Amiodarone Hydrochloride
Lopac0_000122
Lopac-A-8423
LS-87088
MolPort-003-703-670
NCGC00015096-01
NCGC00015096-02
NCGC00015096-03
NCGC00015096-10
NCGC00024242-03
NCGC00024242-04
NCGC00024242-05
NCGC00024242-06
nchembio.79-comp9
nchembio732-comp1
NCI60_041885
NINDS_000079
on
Ortacrone
Pacerone
Pharma investi brand OF amiodarone hydrochloride
Pharma Investi Brand of Amiodarone Hydrochloride
pms-Amiodarone
Prestwick0_000409
Prestwick1_000409
Prestwick2_000409
Prestwick3_000409
QTL1_000008
Rytmarone
Sanofi winthrop brand OF amiodarone hydrochloride
Sanofi Winthrop Brand of Amiodarone Hydrochloride
Sedacoron
Sedacorone
SKF 33134 a
SKF 33134-a
SKF 33134A
SKF 33134-A
SPBio_001825
SPBio_002277
Spectrum_000261
Spectrum2_001813
Spectrum3_001050
Spectrum4_001190
Spectrum5_001533
STK529812
STOCK1S-12240
Tachydaron
Trangorex
UNII-N3RQ532IUT
UNM000001215003
Wyeth brand OF amiodarone hydrochloride
Wyeth Brand of Amiodarone Hydrochloride
|
|
9 |
|
Isosorbide Dinitrate |
Approved, Investigational |
Phase 4 |
|
87-33-2 |
6883 |
Synonyms:
[(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate
1,4:3, 6-Dianhydro-D-glucitol dinitrate
1,4:3,6-dianhydro-2,5-di-O-nitro-D-glucitol
1,4:3,6-Dianhydro-D-glucitol dinitrate
1,4:3,6-Dianhydrosorbitol 2, 5-dinitrate
1,4:3,6-Dianhydrosorbitol 2,5-dinitrate
1,4:3,6-Dianhydrosorbitol 2,5-dinitric acid
54650-95-2
59812_ALDRICH
59812_FLUKA
6659-58-1
87-33-2
AB00513900
AC-12153
AC1L1NIG
Angidil
Astridine
BiDil
BPBio1_001021
BSPBio_000927
BSPBio_002080
C07456
C6H8N2O8
Cardio 10
Cardis
Cardonit 40
Carvanil
Carvasin
CCRIS 1910
Cedocard
Cedocard retard
Cedocard Retard
CHEBI:6061
CID6883
Claodical
Cornilat
Coronex
Corosorbide
Corovliss
D00516
D007548
DB00883
D-Glucitol, 1,4:3,6-dianhydro-, 2,5-dinitrate
D-Glucitol, 1,4:3,6-dianhydro-, dinitrate
Dianhydrosorbitol 2,5-dinitrate
Dianhydrosorbitol 2,5-dinitric acid
Difutrat
Dignionitrat
Dilatrate
Dilatrate SR
Dilatrate-SR
Dilatrate-sr (TN)
Dilatric acid-SR
Diniket
Dinitrate d'isosorbide
Dinitrate d'isosorbide [INN-French]
Dinitrate, isosorbide
Dinitrate, Isosorbide
Dinitrato de isosorbida
Dinitrato de isosorbida [INN-Spanish]
Dinitric acid d'isosorbide
Dinitroisosorbide
Dinitrosorbide
Disorlon
D-Isosorbide dinitrate
D-Isosorbide dinitrate-Lactose mixture
D-Isosorbide dinitric acid
DivK1c_000436
EINECS 201-740-9
Emoper
EureCor
Flindix
Frandol
Glucitol, 1,4:3, 6-dianhydro-, dinitrate,
Harrical
HMS1570O09
HMS1920H15
HMS2091P05
HMS501F18
HSDB 3417
IBD 20
IDI1_000436
ISD
ISDN
Ismotic
Iso bid
Iso Bid
Iso-bid
IsoBid
Iso-Bid
Isochron
Isodinit
Isoket
Isoket retard 120
Isoket Retard 120
Isoket retard 40
Isoket retard120
Isoket retard-120
Isoket Retard120
|
Isoket Retard-120
Iso-Mack
Isomak R
Iso-Puren
Isorbid
Isordil
Isordil (TN)
Isordil Tembids
Isosorbide 2,5-dinitrate
Isosorbide 2,5-dinitric acid
Isosorbide dinitrate
ISOSORBIDE DINITRATE
Isosorbide dinitrate (JP15/USP/INN)
Isosorbide dinitrate [USAN:INN:BAN:JAN]
Isosorbide dinitrate mixture with not <60% lactose, mannose, starch or calcium hydrogen phosphate [UN2907] [Flammable solid]
Isosorbide dinitrate mixture with not <60% lactose, mannose, starch or calcium hydrogen phosphate [UN2907] [Flammable solid]
Isosorbide dinitrato
Isosorbide dinitrato [DCIT]
Isosorbide dinitric acid
Isosorbidi dinitras
Isosorbidi dinitras [INN-Latin]
Isosorbidi nitras
Isostat
Isotrate
KBio1_000436
KBio2_000643
KBio2_003211
KBio2_005779
KBio3_001580
KBioGR_000429
KBioSS_000643
Korodil
Langoran
Laserdil
Lomilan
LS-71376
Maycor
MLS001333561
MLS001333562
MolPort-003-666-213
Myorexon
NCGC00178830-01
NCGC00178830-02
NINDS_000436
Nitrosorbid
Nitrosorbide
Nitrosorbon
Nosim
NSC 80038
NSC80038
Prestwick_81
Prestwick0_000714
Prestwick1_000714
Prestwick2_000714
Prestwick3_000714
Resoidan
Rifloc Retard
Rigedal
SDM No. 40
SDM No. 50
SMR000857256
Sorate-10
Sorate-5
Sorbangil
Sorbide
Sorbide nitrate
Sorbide nitric acid
Sorbide T.D.
Sorbide, dinitrate
Sorbidi nitras
Sorbidilat
Sorbidinitrate
Sorbidnitrate
Sorbidnitric acid
Sorbislo
Sorbitrate
Sorbonit
Sorquad
Sorquat
SPBio_001058
SPBio_002848
Spectrum_000163
SPECTRUM1500358
Spectrum2_001069
Spectrum3_000600
Spectrum4_000025
Spectrum5_001057
SST-101
Tinidil
Titradose
TYB 3215
UN2907
UNII-IA7306519N
Vascardin
Vasodilat
Vasorbate
Xanyl
ZINC18089317
|
|
10 |
|
AT-101 |
Approved, Investigational |
Phase 4 |
|
90141-22-3, 652-67-5 |
12597 |
Synonyms:
(+)-D-Isosorbide
(3S,3aR,6R,6aR)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol
1,4:3,6-Dianhydro-D-glucitol
1,4:3,6-Dianhydro-D-sorbitol
1,4:3,6-Dianhydroglucitol
1,4:3,6-dianhydrohexitol
1,4:3,6-Dianhydromannitol
1,4:3,6-Dianhydrosorbitol
1,4-Dianhydrosorbitol
151380-60-8
152881-21-5
2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol
24332-71-6
28218-68-0
42750-75-4
49871-92-3
50974-60-2
5-19-03-00201 (Beilstein Handbook Reference)
641-74-7
652-67-5
67803-92-3
A912284D-27E1-4FB0-91B8-86C8AB905297
AC1L1ZXO
AC1L4190
AC1Q79SL
AR-1B7417
AT 101
AT101
AT-101
BIDD:GT0695
Bio-0643
BRN 0080510
CHEMBL1200660
CID12597
CID99937
D00347
D-1,4:3,6-Dianhydroglucitol
Devicoran
Dianhydro-D-glucitol
Dianhydrosorbitol
|
D-Sorbitol, {1,4:3,6-dianhydro(furo[3,2-b]furan-3,6-diol,} hexahydro-)
D-Sorbitol, 1,4:3,6-dianhydro(furo[3,2-b]furan-3,6-diol, hexahydro-)
EINECS 211-374-1
EINECS 211-492-3
EINECS 248-906-7
HSDB 3105
Hydronol
Hydronol (VAN)
I0407
I14-6752
Ismotic
Ismotic (TN)
Isobide
Isobide (TN)
Isomannide
Isosorbida
Isosorbida [INN-Spanish]
isosorbide
Isosorbide (JP15/USP/INN)
Isosorbide [USAN:INN:BAN:JAN]
Isosorbidum
Isosorbidum [INN-Latin]
KST-1B7297
LS-71370
LS-89261
MolPort-000-812-960
MolPort-001-783-404
NCGC00160508-01
NSC 40725
NSC231906
NSC270938
NSC40725
Oprea1_439690
SMP1_000177
Sorbid
STK801813
TL8004635
UNII-WXR179L51S
Vascardin dinitrate
ZINC18284778
|
|
11 |
|
alemtuzumab |
Approved, Investigational |
Phase 4 |
|
216503-57-0 |
|
Synonyms:
|
12 |
|
carbamide peroxide |
Approved |
Phase 4 |
|
124-43-6 |
|
Synonyms:
Carbamide peroxide
Hydrogen peroxide carbamide
Urea dioxide
|
Urea hydrogen peroxide
Urea peroxide
|
|
13 |
|
Rocuronium |
Approved |
Phase 4 |
|
119302-91-9, 143558-00-3 |
441290 |
Synonyms:
(2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-16-(1-allylpyrrolidinium-1-yl)-3-hydroxy-2-(morpholin-4-yl)androstane
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
143558-00-3
AC1L9AWM
BIDD:GT0360
C07556
CHEBI:8884
CID441290
DB00728
|
Esmeron
Esmerone
HMS2090E03
NCGC00167433-01
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
Rocuronio
Rocuronium
Rocuronium bromide
Zemuron
|
|
14 |
|
Doxazosin |
Approved |
Phase 4 |
|
74191-85-8 |
3157 |
Synonyms:
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone
1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine
1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[4-(1,4-benzodioxan-2-yl)carpiperazin-1-yl)]-6,7-dimethoxyquinazoline mesylate
2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-bis(methyloxy)quinazolin-4-amine
2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
2-{4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine
74191-85-8
77883-43-3 (mesylate)
AC-11062
AC1L1FAT
AC1Q470P
AC1Q4EXN
AKOS001681453
Alfamedin
Aliud brand OF doxazosin mesylate
Almirall brand OF doxazosin mesylate
Alpharma brand OF doxazosin mesylate
Alter brand OF doxazosin mesylate
Apo doxazosin
Apo-doxazosin
Apogepha brand OF doxazosin mesylate
Apotex brand OF doxazosin mesylate
AstraZeneca brand OF doxazosin mesylate
Azupharma brand OF doxazosin mesylate
Betapharm brand OF doxazosin mesylate
BPBio1_000963
BRD-A13188892-066-03-3
BSPBio_000875
C06970
C23H25N5O5
Cantabria brand OF doxazosin mesylate
Cardular
Cardura
Cardura XL
Cardura XL (TN)
Cardura-1
Cardura-2
Cardura-4
Carduran
Carduran neo
CHEBI:4708
CHEMBL707
ChemDiv2_005017
Ciclum brand OF doxazosin mesylate
CID3157
Cinfa brand OF doxazosin mesylate
Combino brand OF doxazosin mesylate
CPD000097306
CT Arzneimittel brand OF doxazosin mesylate
CT, Doxazosin von
CT-Arzneimittel brand OF doxazosin mesylate
D07874
D9815_SIGMA
DB00590
Diblocin
Doxa puren
Doxacor
Doxagamma
Doxamax
Doxa-puren
Doxatensa
DoxaUro
Doxazomerck
doxazosin
Doxazosin
Doxazosin (INN)
Doxazosin [INN:BAN]
Doxazosin al
Doxazosin apogepha
Doxazosin azu
Doxazosin beta
Doxazosin findusfit
Doxazosin heumann
Doxazosin klast
Doxazosin mesilate
Doxazosin mesylate
Doxazosin monohydrochloride
Doxazosin ratiopharm
|
Doxazosin stada
Doxazosin von CT
Doxazosin wolff
Doxazosina
Doxazosina [Spanish]
Doxazosina alter
Doxazosina cinfa
Doxazosina combino pharm
Doxazosina geminis
Doxazosina normon
Doxazosina pharmagenus
Doxazosina ratiopharm
Doxazosina ur
Doxazosine
Doxazosine [French]
Doxazosin-ratiopharm
Doxazosinum
Doxazosinum [Latin]
Doxazosin-wolff
Esparma brand OF doxazosin mesylate
FindusFit brand OF doxazosin mesylate
Geminis brand OF doxazosin mesylate
Gen doxazosin
Gen-doxazosin
Genpharm brand OF doxazosin mesylate
Heumann brand OF doxazosin mesylate
Hexal brand OF doxazosin mesylate
HMS1383E01
HMS2090C20
I06-1346
IDI1_003732
Juta brand OF doxazosin mesylate
Jutalar
Kade brand OF doxazosin mesylate
L000738
Linden brand OF doxazosin mesylate
Lopac0_000474
LS-110228
Merck dura brand OF doxazosin mesylate
Mesylate, doxazosin
MolPort-001-684-491
Monohydrochloride, doxazosin
MTW Brand OF doxazosin mesylate
MTW Doxazosin
MTW-Doxazosin
NCGC00018158-06
NCGC00089775-02
Neo, carduran
Normon brand OF doxazosin mesylate
Normothen
Novo doxazosin
Novo-doxazosin
Novopharm brand OF doxazosin mesylate
Oprea1_259518
Pfizer brand OF doxazosin mesylate
Pharmagenus brand OF doxazosin mesylate
Prestwick0_000858
Prestwick1_000858
Prestwick2_000858
Prestwick3_000858
Progandol neo
Q Pharm brand OF doxazosin mesylate
Q-Pharm brand OF doxazosin mesylate
Ratio doxazosin
Ratio-doxazosin
Ratiopharm brand OF doxazosin mesylate
Ratiopharm, doxazosina
SAM002589981
Solvay brand OF doxazosin mesylate
SPBio_002796
Stadapharm brand OF doxazosin
TAD brand OF doxazosin mesylate
UK 33274
UK-33274
UNII-NW1291F1W8
Uriduct
Von CT, doxazosin
Wolff brand OF doxazosin mesylate
Wörwag brand OF doxazosin mesylate
Zoxan
|
|
15 |
|
Atenolol |
Approved |
Phase 4 |
|
29122-68-7 |
2249 |
Synonyms:
( inverted question mark)-Atenolol
(?)-Atenolol
(+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide
(+-)-Atenolol
(+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide
(1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid
2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide
2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide
2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide
29122-68-7
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
4-[2 -Hydroxy-3 -(isopropylamino)-propoxy]phenylacetamide
4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide
60966-51-0
A 7655
A7655_SIGMA
AC-11142
AC1L1D99
AC1Q1QBX
Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)
Aircrit
AKOS005111050
Alinor
Altol
Anselol
Antipressan
Apo-atenolol
Apo-Atenolol
ARONIS23884
Atcardil
Atecard
Atehexal
Atenblock
Atendol
Atenet
Ateni
Atenil
Atenol
Atenol 1a pharma
Atenol 1A pharma
Atenol 1A Pharma
Atenol acis
Atenol Acis
Atenol al
Atenol AL
Atenol atid
Atenol Atid
Atenol cophar
Atenol Cophar
Atenol ct
Atenol CT
Atenol fecofar
Atenol Fecofar
Atenol gador
Atenol Gador
Atenol genericon
Atenol Genericon
Atenol GNR
Atenol heumann
Atenol Heumann
Atenol MSD
Atenol NM pharma
Atenol NM Pharma
Atenol nordic
Atenol Nordic
Atenol PB
Atenol quesada
Atenol Quesada
Atenol stada
Atenol Stada
Atenol tika
Atenol Tika
Atenol trom
Atenol Trom
Atenol von ct
Atenol von CT
Atenol Von CT
Atenolin
Atenol-mepha
Atenol-Mepha
atenolol
Atenolol
Atenolol (JP15/USP/INN)
Atenolol [USAN:INN:BAN:JAN]
Atenololum
Atenololum [INN-Latin]
Atenol-ratiopharm
Atenol-Ratiopharm
Atenol-wolff
Atenol-Wolff
Atenomel
Atereal
Aterol
BB_SC-1519
benzeneacetamide, 4-[2'-hydroxy-3
Betablok
Betacard
Betasyn
Betatop ge
Betatop Ge
Betatop GE
BIM-0050109.0001
Blocotenol
Blokium
BRD-A20239487-001-02-5
BRN 2739235
BSPBio_002915
Cardaxen
Cardiopress
CCRIS 4196
CHEBI:2904
CHEMBL24
CID2249
|
Corotenol
CPD000036768
Cuxanorm
D001262
D00235
DB00335
DivK1c_000057
Duraatenolol
duratenol
Duratenol
EINECS 249-451-7
EINECS 262-544-7
EU-0100121
Evitocor
Farnormin
Felo-bits
Felo-Bits
Hipres
HMS1569L13
HMS1921H09
HMS2090I19
HMS2092D19
HMS500C19
HSDB 6526
Hypoten
I01-3572
Ibinolo
ICI 66,082
ICI 66082
ICI66082
ICI-66082
IDI1_000057
InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
Internolol
Jenatenol
Juvental
KBio1_000057
KBio2_001844
KBio2_004412
KBio2_006980
KBio3_002415
KBioGR_000790
KBioSS_001844
L000116
Lopac0_000121
Loten
Lo-ten
Lo-Ten
Lotenal
LS-28557
LS-9707
MLS000069622
MLS001066372
MLS001074163
MLS001304038
MolPort-001-792-717
Myocord
NCGC00015007-07
NCGC00015007-13
NCGC00024566-03
NCGC00024566-04
NCGC00024566-05
NCGC00024566-06
NCGC00024566-07
Neatenol
NINDS_000057
Normalol
Normiten
Noten
Oprea1_448775
Oraday
Ormidol
Panapres
Plenacor
Premorine
Prenolol
Prenormine
Prinorm
SAM002564193
Scheinpharm atenol
Scheinpharm Atenol
Seles beta
Seles Beta
Selobloc
Serten
Servitenol
SMR000036768
SPBio_001482
Spectrum_001364
SPECTRUM1501127
Spectrum2_001411
Spectrum3_001448
Spectrum4_000435
Spectrum5_001509
Stermin
STK528649
Tenidon
Teno-basan
Teno-Basan
Tenobloc
Tenoblock
Tenolol
Tenoprin
Tenoretic
Tenormin
Tenormin (TN)
Tenormine
Tenormine [French]
Tensimin
Tensotin
Tredol
Unibloc
UNII-50VV3VW0TI
Uniloc
Vascoten
Vericordin
Wesipin
Xaten
|
|
16 |
|
Clonidine |
Approved |
Phase 4 |
|
4205-90-7 |
2803 |
Synonyms:
1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)
2-((2,6-Dichlorophenyl)imino)imidazolidine
2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)
2-(2,6-Dichloroanilino)-2-imidazoline
2-(2,6-Dichlorophenylamino)-2-imidazoline
2-(2,6-Dichlorophenylimino)imidazolidine
2,6-dichloro-N-(2-imidazolidinylidene)aniline
2,6-dichloro-N-2-imidazolidinylidenebenzenamide
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2,6-dichloro-N-imidazolidin-2-ylideneaniline
2-[(2,6-dichlorophenyl)imino]-2-imidazoline
2-[(2,6-Dichlorophenyl)imino]imidazoline
2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)
4205-90-7
4205-91-8 (mono-hydrochloride)
57066-25-8
734571A
AB00514634
AC1L1EI5
AC1Q3K6V
Adesipress
AKOS001595470
BIDD:GT0547
Bio1_000470
Bio1_000959
Bio1_001448
Bio2_000308
Bio2_000788
Boehringer ingelheim brand OF clonidine hydrochloride
BPBio1_000040
BRD-K98530306-001-02-1
BRD-K98530306-003-05-0
BSPBio_000036
BSPBio_001588
BSPBio_002055
C9H9Cl2N3
CAS-4205-91-8
Catapres
Catapres- TTS
Catapresan
Catapressan
Catapres-TTS
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
Catarpres
Catarpresan
Catarpres-TTS
Catarpres-TTS (TN)
CCRIS 7787
CHEBI:3757
CHEBI:46632
CHEMBL134
Chlofazoline
Chlophazolin
Chlornidinum
CID2803
Clofelin
Clofenil
Clonidin
Clonidina
Clonidina [INN-Spanish]
clonidine
Clonidine
Clonidine (JAN/USAN/INN)
Clonidine [USAN:BAN:INN]
Clonidine dihydrochloride
Clonidine HCl
Clonidine hydrochloride
Clonidine monohydrobromide
Clonidine monohydrochloride
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
D00281
DB00575
|
DB07566
Dihydrochloride, clonidine
DivK1c_000774
Dixarit
Duraclon
Duraclont
EINECS 224-119-4
Gemiton
Hemiton
HMS1361P10
HMS1791P10
HMS1989P10
HMS2089G11
HSDB 3040
Hydrochloride, clonidine
IDI1_000774
IDI1_034058
Ipotensium
Isoglaucon
KBio1_000774
KBio2_000308
KBio2_001821
KBio2_002876
KBio2_004389
KBio2_005444
KBio2_006957
KBio3_000615
KBio3_000616
KBio3_001275
KBioGR_000308
KBioGR_001572
KBioSS_000308
KBioSS_001821
Klofelin
Klofenil
L000193
Lopac0_000268
Lopac-C-7897
LS-79606
M 5041T
M-5041T
MolPort-001-779-668
MolPort-005-932-374
Monohydrobromide, clonidine
Monohydrochloride, clonidine
N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
NCGC00015268-01
NCGC00015268-02
NCGC00015268-08
NCGC00024734-01
NCGC00024734-02
NCGC00024734-03
NCGC00024734-04
NCGC00024734-05
NCGC00179680-01
nchembio.79-comp11
nchembio705-10
NINDS_000774
Prestwick0_000248
Prestwick1_000248
Prestwick2_000248
Prestwick3_000248
SKF 34427
SPBio_001233
SPBio_002255
Spectrum_001341
Spectrum2_001187
Spectrum3_000358
Spectrum4_000956
Spectrum5_000759
ST 155BS
ST-155BS
ST-155-BS
T171
Tenso-Timelets
Tocris-0690
UNII-MN3L5RMN02
ZINC00896484
|
|
17 |
|
Irbesartan |
Approved, Investigational |
Phase 4 |
|
138402-11-6 |
3749 |
Synonyms:
138402-11-6
2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one
2-butyl-3-[ p -( o -1 H -tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4,4]non-1-en-4-one
2-butyl-3-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[
2-butyl-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[
2-Butyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one
2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-n-butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one
AC1L1GMK
AC-537
Aprovel
Avalide
Avapro
Avapro (TN)
BIDD:GT0347
Bio-0053
BMS 186295
BMS Brand of Irbesartan
BMS-186295
BMS-186295, SR-47436, Aprovel, Karvea, Irbesartan
BRD-K60038276-001-02-5
Bristol Myers Brand of Irbesartan
BSPBio_002687
C07469
C081309
C25H28N6O
CHEBI:5959
CHEMBL1513
CID3749
CPD000466306
D00523
DB01029
HMS1922J05
HMS2051L08
HMS2093E16
I06-0690
|
Irbesarran
irbesartan
Irbesartan
Irbesartan (JAN/USAN/INN)
Irbesartan [Usan:Inn]
Irbesartan [USAN:INN]
Irbetan
Jsp002315
Karvea
KBio2_002231
KBio2_004799
KBio2_007367
KBio3_001907
KBioGR_001603
KBioSS_002231
L000319
Lrbesartan
LS-60064
MLS000759408
MLS001424099
MolPort-003-666-550
NCGC00095122-01
NCGC00095122-02
NCGC00095122-03
S1507_Selleck
SAM001246548
Sanofi Winthrop Brand of Irbesartan
SMR000466306
SPBio_001889
Spectrum_001751
SPECTRUM1504259
Spectrum2_001675
Spectrum3_000994
Spectrum4_001122
Spectrum5_001288
SR 47436
SR-47436
STK645362
TL8000875
UNII-J0E2756Z7N
|
|
18 |
|
Olmesartan |
Approved, Investigational |
Phase 4 |
|
144689-24-7, 144689-63-4 |
158781 130881 |
Synonyms:
144689-24-7
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
4-(Hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid
5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid
AC1L4KLS
Benicar
Benicar HCT
C437965
CHEBI:48416
CHEMBL1516
CID158781
CPD000466337
CS-088
D05246
DE-092
|
HMS2051K12
I14-10085
L001097
LS-181800
MLS000759446
MLS001424016
MolPort-003-666-606
olmesartan
Olmesartan
Olmesartan (USAN/INN)
Olmesartan [USAN]
Olmesartan medoximil
Olmesartan medoxomil
Olmetec
omesartan
Omesartan
RNH 6270
RNH-6270
SAM001246634
SMR000466337
UNII-8W1IQP3U10
Votum
|
|
19 |
|
Metformin |
Approved |
Phase 4 |
|
657-24-9 |
14219 4091 |
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
cMAP_000016
D04966
DB00331
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMGG
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
Haurymelin
HMS2089D19
HSCI1_000295
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
|
KBioSS_002312
LA-6023
LS-43899
Melbin
metformin
Metformin
Metformin (USAN/INN)
Metformin [USAN:INN:BAN]
Metformin HCL
metformin hydrochloride
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
Sandoz Metformin
Siofor
SPBio_001928
STK011633
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
|
|
20 |
|
Aminophylline |
Approved |
Phase 4 |
|
317-34-0 |
9433 |
Synonyms:
111079-49-3
12767-26-9
2a3a
317-34-0
442519-87-1
46157-00-0
56645-32-0
5768-49-0
58-55-9
75448-53-2
8013-40-9
80186-94-3
95646-60-9
A 1755
A1755_SIGMA
AB00052106
AC-11138
AC1L1D1F
AC1L1T14
AC1L9AQ0
AC-20328
Accurbron
Acet-theocin
Aerobin
Aerolate
Aerolate III
Aerolate SR
Afonilm
Afonilum
AI3-50216
Aminocardol
Aminodur
Aminofilina
Aminofillina
Aminophyllin
Aminophylline
Aminophyllinum
Ammophyllin
Aquaphyllin
Armophylline
Asmalix
Asmax
Austyn
BIDD:ER0557
BIDD:GT0151
Bilordyl
Bio-0793
Bronchoparat
Bronkodyl
Bronkodyl SR
Bronkotabs
BY 108
C07130
C7H8N4O2
Cardiofilina
Cardiomin
Cardophylin
Cardophyllin
Carena
Cariomin
CAS-317-34-0
CCRIS 4729
CHEBI:28177
CHEMBL1210
CHEMBL190
Choledyl SA
CID2153
CID441189
CID9433
Constant T
ConstantT
Constant-T
CPD000058537
CPD-12479
ct, theo von
D00227
D00371
D013806
D05429
DB00277
DB01223
Diaphilline
Diaphyllin
Diaphylline
Diffumal
Diophllin
Diophyllin
Diuxanthine
DOBO
Doraphyllin
Duraphyl
Duraphyllin
Egifilin
Elixex
Elixicon
Elixomin
Elixophyllin
Etheophyl
Ethophylline
EU-0100014
Eufilina
Euphyllin
Euphylline
Euphyllinum
Euphylong
Eurphyllin
Euufilin
Euufillin
Genophyllin
Grifomin
GS 2591A
HMS1570D21
HMS1921E03
HMS2089A06
HMS2092M05
HMS500K05
HSDB 221
HSDB 3399
Hylate
IDI1_000203
Inophylline
KBio1_000203
KBio2_001518
KBio2_004086
KBio2_006654
KBio3_001583
L000595
LaBID
Labophylline
Lanophyllin
LASMA
Lasodex
Linampheta
Lixaminol
Lopac-A-1755
LS-149548
LS-241
Maphylline
Medaphyllin
Metaphyllin
Metaphylline
Minaphil
Miofilin
MLS000069390
MLS002152943
MLS002153487
Mudrane
|
NCI60_001736
Neophyiline
NINDS_000203
Norofilina
NSC 2066
NSC 7919
NSC2066
Nuelin
Nuelin S.A
Nuelin S.A.
Nuelin SA
Optiphyllin
Parkophyllin
PDSP1_001018
PDSP1_001234
PDSP2_001002
PDSP2_001218
Peterphyllin
Phylcardin
Phyllindon
Phyllocontin
Phyllotemp
Physpan
Prestwick_93
Pro-vent
Pulmidur
Quibron
Quibron T
Quibron T SR
Quibron T/SR
Quibron TSR
Quibron T-SR
Quibron-T
Quibron-T/SR
Respbid
Respicur
Respid
SAM002554935
Slo Phyllin
Slo-bid
Slo-phyllin
SloPhyllin
SMP1_000291
SMR000058537
Solosin
Somophyllin
SomophyllinT
SPBio_000823
SPBio_002640
SPBio_002866
ST024762
ST50298827
ST50298884
Stenovasan
STK397040
Sustaire
Synophylate
Syntophyllin
T0179
T1633_SIGMA
T4924_SIGMA
T7770_SIGMA
T9031_SIGMA
Talotren
Tefamin
Telb-DS
Teocen 200
Teofilina
Teofyllamin
Teolair
Teonova
Teosona
Tesona
TH/100
Theacitin
Theo 24
Theo Dur
theo von ct
Theo-11
Theo24
Theo-24
Theo-24 (TN)
Theobid
THEOBID JR
Theobid Jr.
Theochron
Theocin
Theoclair-SR
Theoclear
Theoclear 80
Theoclear LA
Theoclear-80
Theocontin
Theodel
Theodrip
Theodrox
Theo-DS
Theodur
Theo-dur
Theodur G
Theofol
Theograd
Theokin
Theolair
Theolair-SR
Theolamine
Theolix
Theolixir
Theolone
Theomin
Theona P
Theonite
Theo-Nite
Theopek
Theophyl
Theophyl-225
Theophyldine
Theophyline
Theophyline ethylenediamine
Theophyllin
theophylline
Theophylline ethylenediamine
Theophyl-SR
Theoplus
Theo-Sav
Theospan
Theostat
Theostat 80
Theotard
Theovent
Thephyldine
T-Phyl
Truphylline
Uni-Dur
Unifyl
Unilong
Uniphyl
Uniphyl (TN)
Uniphyllin
Uniphylline
UPCMLD-DP123
Vasofilina
von ct, theo
X 115
Xanthium
Xantivent
ZINC18043251
|
|
21 |
|
Regadenoson |
Approved, Investigational |
Phase 4 |
|
313348-27-5 |
219024 |
Synonyms:
|
22 |
|
Candesartan cilexetil |
Approved |
Phase 4 |
|
145040-37-5 |
2540 |
Synonyms:
(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
145040-37-5
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
AC1L1DWQ
AC-204
Almirall brand of candesartan cilexetil
Amias
Astra brand of candesartan cilexetil
AstraZeneca brand of candesartan cilexetil
Atacand
Atacand (TN)
ATACAND HCT
BRD-A65671304-001-02-6
BSPBio_002691
C07709
C077793
C33H34N6O6
Candesartan cilexetil
Candesartan cilexetil (JAN/USAN)
Candesartan cilexetil [USAN]
candesartan cilexitil
Candesartan hexetil
CHEBI:216349
CHEMBL1014
CID2540
D00626
FT-0082579
H212/91
|
HMS1922J09
HMS2093E20
I06-0090
KBio2_002187
KBio2_004755
KBio2_007323
KBio3_001911
KBioGR_001607
KBioSS_002187
Kenzen
L006257
LS-32741
MolPort-003-666-552
NCGC00095123-01
NCGC00095123-02
NCGC00095123-03
Parapres
Promed brand of candesartan cilexetil
Racanda
SPBio_000349
Spectrum_001707
SPECTRUM1504261
Spectrum2_000485
Spectrum3_000996
Spectrum4_001124
Spectrum5_001462
ST51052687
Takeda brand of candesartan cilexetil
TCV 116
TCV-116
TL8000995
UNII-R85M2X0D68
|
|
23 |
|
Bortezomib |
Approved, Investigational |
Phase 4 |
|
179324-69-7 |
387447 93860 |
Synonyms:
[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid
[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
179324-69-7
341, PS
AC1L8TUW
bortezomib
Bortezomib
Bortezomib (JAN/USAN/INN)
CHEBI:287372
CHEBI:41143
CHEMBL325041
CID387447
D03150
DB07475
DPBA
FT-0082488
I14-3268
LDP 341
LDP341
LDP-341
|
LPD 341
LPD-341
MLN341
MolPort-003-845-298
N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide
N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE
NCI60_029010
NSC681239
NSC-681239
PROSCRIPT BORONIC ACID
PS 341
PS-341
Pyz-Phe-boroLeu
S1013_Selleck
SBB071337
Velcade
Velcade (TN)
Velcade, MG-341, PS-341, Bortezomib
|
|
24 |
|
Colchicine |
Approved |
Phase 4 |
|
64-86-8 |
6167 2833 |
Synonyms:
(S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide
30512-31-3
5843-86-7
64-86-8
7.alpha.H-Colchicine
7alphaH-Colchicine
7-alpha-H-Colchicine
AC1L1LXO
ACon1_000353
AI3-31149
AKOS001582887
BB_NC-0737
Benzo(a)heptalen-9(5H)-one
binds to tubulin
BPBio1_000535
BRD-K00259736-001-06-5
BSPBio_000485
BSPBio_002083
C 9754
C07592
C22H25NO6
C3915_SIGMA
C9754_SIGMA
CCRIS 691
CHEBI:27882
CHEMBL107
CID6167
Colchicin
Colchicin [German]
Colchicina
Colchicina [Italian]
colchicine
Colchicine
Colchicine (JP15/USP)
Colchicine (TN)
Colchicine [JAN]
Colchicine, (+-)-Isomer
Colchicine, (R)-Isomer
Colchicine, Colchicum autumnale
Colchicinum
Colchineos
Colchisol
Colchysat
Colcin
Colcrys
Colsaloid
Colstat
Condylon
CPD-9785
D003078
D00570
DB01394
DB08117
DivK1c_000753
EINECS 200-598-5
EU-0100310
Goutnil
HMS1569I07
HMS1920A08
HMS2091G16
HMS502F15
HSDB 3044
IDI1_000753
inhibits microtubular assembly
KBio1_000753
|
KBio2_001322
KBio2_003890
KBio2_006458
KBio3_001303
KBioGR_000856
KBioSS_001322
Kolkicin
LOC
Lopac0_000310
LS-279
MEGxp0_001879
MLS001055448
MLS001055448-02
MLS001304089
MLS002153786
MolPort-001-742-594
MPC-004
N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)- acetamide
N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)acetamide
N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-acetamide
N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide
N-Acetyl trimethylcolchicinic acid methylether
NCGC00025125-01
NCGC00025125-02
NCGC00025125-03
NCGC00025125-04
NCGC00025125-05
NCGC00025125-06
NCGC00025125-07
NCGC00025125-11
NCGC00169157-01
NCGC00169157-02
NCGC00169157-03
NChemBio.2007.10-comp20
nchembio853-comp2
NCI60_041659
NINDS_000753
NSC 757
NSC757
Prestwick_695
Prestwick0_000363
Prestwick1_000363
Prestwick2_000363
Prestwick3_000363
S2284_Selleck
SDCCGMLS-0066633.P001
SMR000058323
SPBio_000289
SPBio_002406
Spectrum_000842
SPECTRUM1500205
Spectrum2_000075
Spectrum3_000362
Spectrum4_000298
Spectrum5_000787
spindle poison
Tocris-1364
UNII-SML2Y3J35T
UPCMLD-DP065
UPCMLD-DP065:001
WLN: L B677 MV&T&J CO1 DO1 EO1 JMV1 NO1
ZINC00621853
|
|
25 |
|
Fondaparinux |
Approved, Investigational |
Phase 4 |
|
104993-28-4 |
|
Synonyms:
Natural heparin pentasaccharide
|
|
|
26 |
|
Alprostadil |
Approved, Investigational |
Phase 4 |
|
745-65-3 |
149351 5280723 |
Synonyms:
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(-)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(-)-Prostaglandin e1
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
(+)-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11a,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oate
(11α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
(11Α,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-Oic acid
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11a,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11-alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoate
(13E)-(15S)-11Α,15-dihydroxy-9-oxoprost-13-enoic acid
(13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oate
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid
11,15-Dihydroxy-9-oxoprost-13-en-1-Oic acid (acd/name 4.0)
119314-69-1
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoate
11a,15a-Dihydroxy-9-oxo-13-trans-prostenoic acid
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoate
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoate
11α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid
11Α,15α-dihydroxy-9-oxo-13-trans-prostenoic acid
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
745-65-3
82474_FLUKA
A0593_SIAL
AB00514004
Abbott brand OF alprostadil
AC1NQXHQ
AC-6095
Alista
Allphar brand OF alprostadil
alprostadil
Alprostadil
Alprostadil (JP15/USP/INN)
Alprostadil prostoglandin e1
Alprostadil Prostoglandin E1
Alprostadil(usan)
Alprostadilum
Alprox-TD
Astra brand OF alprostadil
AstraZeneca brand OF alprostadil
Befar
Befar (TN)
BIDD:GT0747
BML1-F06
BPBio1_001293
BRD-K52459643-001-06-0
BSPBio_001175
BSPBio_001488
C04741
Caverject
Caverject impulse
CHEBI:15544
CHEMBL495
CID5280723
CPD000112594
D00180
|
DB00770
Edex
FemLife
Femprox
HEI-507
HMS1361K10
HMS1571K17
HMS1791K10
HMS1989K10
HMS2052L11
HMS2090L08
Hoyer brand OF alprostadil
IDI1_033958
Janssen brand OF alprostadil
Lipo pge1
Lipo-pge1
LMFA03010134
l-Prostaglandin E1
L-Prostaglandin e1
Minprog
MLS000758964
MLS001424250
MolPort-003-939-183
MR 256
MR-256
Muse
NCGC00025234-02
NCGC00025234-03
NCGC00025234-04
NCGC00025234-05
P5515_SIAL
P5515_SIGMA
P7527_SIGMA
P8908_SIGMA
Paladin brand OF alprostadil
PGE1
PGE-1
PGE1 Oligomer
PGE1alpha
Pharmacia brand 1 OF alprostadil
Pharmacia brand 2 OF alprostadil
Prestwick2_001018
Prestwick3_001018
Prink
Prink (TN)
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer
Prostaglandin e1
Prostaglandin E1
Prostaglandin e1alpha
Prostavasin
Prostin VR
Prostin VR pediatric
Prostin VR Pediatric
Prostin VR pediatric (TN)
Prostine VR
RayVa
SAM001246840
SAM001246845
SAM001247093
Schwarz brand OF alprostadil
Schwarz pharma brand OF alprostadil
SMP2_000271
SMR000112594
ST50826271
Sugiran
Topiglan
U-10136
U-10136alprostadil
U-10136prostin
Vasaprostan
Viridal
Vitaros
Vivus brand OF alprostadil
|
|
27 |
|
Insulin glargine |
Approved |
Phase 4 |
|
160337-95-1 |
|
Synonyms:
Insulin glargine
Insulin glargine (rDNA origin)
|
Insulin glargine recombinant
Insulina glargina
|
|
28 |
|
Gliclazide |
Approved |
Phase 4 |
|
21187-98-4 |
3475 |
Synonyms:
1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea
1-(3-azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea
1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea
1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulphonyl)urea
1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea
1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea
1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulphonyl)urea
21187-98-4
AB00053165
AB1004595
AC-12045
AC1L1G0Q
AKOS003237903
Alphapharm brand OF gliclazide
Bio-0502
BPBio1_000699
BRD-A61154809-001-04-3
BRN 1657836
BSPBio_000635
BSPBio_003304
C15H21N3O3S
CHEBI:31654
CHEMBL427216
CID3475
D01599
DB01120
Diabrezide
Diaglyk
Diaikron
Diamicron
Diamicron MR
DivK1c_006966
EINECS 244-260-5
G2167_SIGMA
Gen gliclazide
Generics brand OF gliclazide
Gen-gliclazide
Genpharm brand OF gliclazide
Gliclazida
Gliclazida [INN-Spanish]
gliclazide
Gliclazide
Gliclazide (JAN/INN)
Gliclazide [BAN:INN:DCF:JAN]
Gliclazide servier brand
Gliclazidum
Gliclazidum [INN-Latin]
Gliklazid
Glimicron
Glimicron (TN)
Glyade
Glyclazide
Helsinn brand OF gliclazide
|
HMS1569P17
HMS1922D15
HMS2090K16
I06-0117
KBio1_001910
KBio2_001958
KBio2_004526
KBio2_007094
KBio3_002806
KBioGR_001096
KBioSS_001958
LS-160299
MLS001215197
MLS001304077
MLS001304118
MolPort-002-507-779
Mylan-Gliclazide
N-(4-Methylbenzenesulfonyl)-n'-(3-azabicyclo(3.3.0)oct-3-yl)urea
N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea
N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide
N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide
NCGC00095107-01
NCGC00095107-02
NCGC00095107-03
NCGC00095107-04
NCGC00095107-05
NCGC00095107-06
Nordialex
Novo gliclazide
Novo-gliclazide
Novopharm brand OF gliclazide
PMS-Gliclazide
Prestwick_869
Prestwick0_000558
Prestwick1_000558
Prestwick2_000558
Prestwick3_000558
S 1702
S 852
S-1702
S-852
SE 1702
Servier brand OF gliclazide
SMR000542971
SPBio_002556
SpecPlus_000870
Spectrum_001478
SPECTRUM1504145
SPECTRUM1505013
Spectrum3_001862
Spectrum4_000598
Spectrum5_000753
STK803142
|
|
29 |
|
Pentoxifylline |
Approved, Investigational |
Phase 4 |
|
6493-05-6 |
4740 |
Synonyms:
1-(5-Oxohexyl)-3,7-dimethylxanthine
1-(5-Oxohexyl)theobromine
1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion
2a3c
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl) xantine
3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxo-hexyl)-3,7-dihydro-purine-2,6-dione
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)xanthine
3,7-Dimethyl-1-(5-oxohexyl)xantine
5-26-14-00081 (Beilstein Handbook Reference)
6493-05-6
AB00052363
AC1L1IUN
Agapurin
Agapurin Retard
AKOS000541484
Azupentat
BAS 00897429
BB_SC-2111
BIDD:GT0174
BL 191
BL191
BL-191
BPBio1_000167
BRD-K57569181-001-05-1
BRN 0558929
BSPBio_000151
BSPBio_003439
C07424
C13H18N4O3
CAS-1677687
CCRIS 6832
CHEMBL628
CID4740
cis-9-Octadecenoyl coenzyme A
CPD000035998
D00501
D010431
DB00806
Dimethyloxohexylxanthine
DivK1c_000729
Durapental
EHT 0201
EHT0201
EHT-0201
EHT-201
EINECS 229-374-5
EU-0100936
Hemovas
HMS1568H13
HMS1922E16
HMS2051N06
HMS2090H13
HMS2093G21
HMS502E11
I06-1592
IDI1_000729
Ikomio
IN1161
KBio1_000729
KBio2_001924
KBio2_004492
KBio2_007060
KBio3_002942
KBioGR_000893
KBioSS_001924
Lopac0_000936
|
Lopac-P-1784
LS-149385
MLS000079026
MLS000758298
MLS001201764
MolPort-001-823-263
NCGC00015801-01
NCGC00015801-02
NCGC00015801-04
NCGC00015801-10
NCGC00067069-02
NCGC00067069-03
NCGC00067069-04
NCGC00067069-05
NCGC00178062-01
NCGC00178062-02
NINDS_000729
NSC 637086
NSC637086
Oxpentifylline
P 1784
PDSP1_001015
PDSP2_000999
Pentoxifilina
Pentoxifilina [INN-Spanish]
Pentoxifyllin
pentoxifylline
Pentoxifylline
Pentoxifylline (JAN/USP/INN)
Pentoxifylline [USAN:INN:JAN]
Pentoxifyllinum
Pentoxifyllinum [INN-Latin]
Pentoxil
Pentoxil (TN)
Pentoxiphyllin
Pentoxiphylline
Pentoxiphyllium
Pentoxyfylline
PENTOXYPHYLINE
Pentoxyphyllin
Pentoxyphylline
PNX
Prestwick_608
Prestwick0_000196
Prestwick1_000196
Prestwick2_000196
Prestwick3_000196
Px
Ralofect
Rentylin
SAM001247011
SMR000035998
SPBio_001221
SPBio_002072
Spectrum_001444
SPECTRUM1503611
Spectrum2_001181
Spectrum3_001820
Spectrum4_000227
Spectrum5_001161
SR-01000075641-4
STK177321
Torental
Trental
Trental (TN)
UNII-SD6QCT3TSU
Vasofirin
Vazofirin
ZINC01530776
|
|
30 |
|
Cinacalcet |
Approved |
Phase 4 |
|
226256-56-0 |
156419 |
Synonyms:
(R)-alpha-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-a-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
(R)-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
(R)-Α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine
073, AMG
1493, KRN
226256-56-0
364782-34-3 (Hydrochloride)
AC1L4G5X
alpha-Methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphar)-hydrochloride
AMG 073
AMG073
CHEBI:48390
CID156419
Cinacalcet
Cinacalcet (USAN)
Cinacalcet [INN]
|
Cinacalcet hydrochloride
CNC
D03504
DB01012
HSDB 7318
Hydrochloride, cinacalcet
I14-3270
LS-187374
Mimpara
MolPort-003-845-954
N-((1R)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine
N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine
N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine
NCGC00181002-01
nchembio.2007.55-comp29
Sensipar
TL8001899
UNII-UAZ6V7728S
|
|
31 |
|
Telavancin |
Approved |
Phase 4 |
|
372151-71-8 |
|
Synonyms:
|
32 |
|
Insulin aspart |
Approved |
Phase 4 |
|
116094-23-6 |
16132418 |
Synonyms:
(AspB28)-human insulin
1024611-56-0
116094-23-6
139532-40-4
28(sup B)-L-Aspartic acid-insulin (human)
877034-90-7
Aspart
Aspart insulin
Aspart Insulin
AspB28-insulin (human)
B28-Aspart-Insulin
B28-Asp-insulin
INA-X 14
Insulin aspart
Insulin aspart [USAN]
|
Insulin aspart protamine
Insulin aspart protamine recombinant
Insulin aspart recombinant
Insulin X14
Insulin, aspart protamine, human
Insulin, aspart, human
Insulin,aspart protamine
Insulina asparta
LS-185932
NovoLog
Novolog mix 70/30
NovoMix 30
NovoRapid
NovoRapid 30 Mix
UNII-D933668QVX
|
|
33 |
|
Hydroxyurea |
Approved |
Phase 4 |
|
127-07-1 |
3657 |
Synonyms:
127-07-1
1-HYDROXYUREA
4-03-00-00170 (Beilstein Handbook Reference)
55291_FLUKA
AC1L1GF8
AC1Q4ZXK
AI3-51139
BB_SC-7256
Bio1_000451
Bio1_000940
Bio1_001429
Biosupressin
BRN 1741548
BSPBio_002164
C07044
carbamide oxide
Carbamohydroxamate
Carbamohydroxamic acid
Carbamohydroxamic Acid
Carbamohydroximate
Carbamohydroximic acid
Carbamohydroximic Acid
Carbamohydroxyamic acid
Carbamohydroxyamic Acid
Carbamoyl oxime
Carbamoyl Oxime
Carbamyl hydroxamate
Carbamyl Hydroxamate
Carbamyl hydroxamic acid
Carrbamoyl Oxime
CCRIS 958
CHEBI:44423
CHEMBL467
CID3657
D00341
D006918
DB01005
DivK1c_000556
DRG-0253
Droxia
Droxia (TM)
Droxia (TN)
E0723DBA-5AF3-49D1-B5F6-59420AB87AC9
EINECS 204-821-7
EU-0100596
FT-0083575
H 8627
H0310
H20210
H8627_SIGMA
Hidrix
Hidroxicarbamida
Hidroxicarbamida [INN-Spanish]
HMS1920F09
HMS2091L17
HMS501L18
HSDB 6887
HU
Hydrea
Hydrea (TM)
HYDREA (TN)
Hydrea, Biosupressin, Cytodrox, Hydroxyurea
Hydreia
Hydroxicarbamidum
hydroxyaminomethanamide
Hydroxycarbamid
Hydroxycarbamide
Hydroxycarbamide (JAN/INN)
Hydroxycarbamidum
Hydroxycarbamidum [INN-Latin]
Hydroxycarbamine
Hydroxyharnstoff
Hydroxyharnstoff [German]
Hydroxylurea
hydroxyurea
Hydroxyurea
HYDROXY-UREA
Hydroxyurea (D4)
|
Hydroxyurea (USP)
Hydroxyurea [USAN:BAN]
Hydroxyurea(d4)
Hydura
Hydurea
I05-0250
IDI1_000556
Idrossicarbamide
Idrossicarbamide [Dcit]
Idrossicarbamide [DCIT]
KBio1_000556
KBio2_001389
KBio2_003957
KBio2_006525
KBio3_001384
KBioGR_000383
KBioSS_001389
Litaler
Litalir
Lopac0_000596
Lopac-H-8627
LS-709
MLS001332381
MLS001332382
MLS002153389
MolMap_000029
MolPort-000-003-971
Mylocel
N-(Aminocarbonyl) Hydroxyamine
N-Carbamoylhydroxylamine
NCGC00015520-01
NCGC00015520-02
NCGC00015520-07
NCGC00093974-01
NCGC00093974-02
NCGC00093974-03
NCGC00093974-04
NCGC00093974-05
nchembio.573-comp3
nchembio.90-comp4
nchembio749-comp3
NCI C04831
NCI60_002773
NCI-C04831
NCIMech_000139
NHY
N-HYDROXY UREA
N-Hydroxymocovina
N-Hydroxymocovina [Czech]
N-Hydroxyurea
N-HYDROXYUREA
NINDS_000556
NSC 32065
NSC32065
Oncocarbide
Onco-carbide
Onco-Carbide
Oxyurea
S1896_Selleck
Siklos
SK 22591
SMR000059149
SPBio_000247
Spectrum_000909
SPECTRUM1500344
Spectrum2_000064
Spectrum3_000462
Spectrum4_000012
Spectrum5_000836
S-phase/G-1 interface inhibitor
SQ 1089
SQ-1089
Sterile Urea
tetratogen: inhibits ribonucleoside diphosphate reductase
TL8000673
UNII-X6Q56QN5QC
Ureaphil
WLN: ZVMQ
|
|
34 |
|
Nifedipine |
Approved |
Phase 4 |
|
21829-25-4 |
4485 |
Synonyms:
101539-70-2
101554-38-5
21829-25-4
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester
5-22-04-00268 (Beilstein Handbook Reference)
60299-11-8 (mono-hydrochloride)
AC-11618
AC1L1I9V
AC1Q4254
Adalat
Adalat (TN)
Adalat 10
Adalat 20
Adalat 5
Adalat CC
Adalat CR
Adalat Crono
Adalat Ft
Adalat FT
Adalat Gits
Adalat GITS
Adalat Gits 30
Adalat GITS 30
Adalat LA
Adalat LP
Adalat Oros
Adalat PA
Adalat Retard
Adalat XL
Adalate
Adalate LP
Adapine
Adapress
Adcock ingram brand OF nifedipine
Adcock Ingram Brand of Nifedipine
Adipine XL
Afeditab
Afeditab CR
Afeditab CR (TN)
AKOS002942507
Alat
Aldipin
Alfadal
Alonix
Alonix S
Alpha-Nifedipine Retard
Angipec
Anifed
Anpine
Apo-Nifed
Aprical
Aprical long
ARONIS24171
AWD pharma brand OF nifedipine
AWD Pharma Brand of Nifedipine
BAY 1040
BAY a 1040
BAY A 1040
Bay1040
Bay-1040
BAY-a 1040
Bay-a-1040
BAYa1040
BAY-a-1040
Bayer brand OF nifedipine
Bayer Brand of Nifedipine
BCBcMAP01_000046
BIDD:GT0442
BIDD:PXR0034
BIM-0050796.0001
Bio-0733
Bio1_000112
Bio1_000601
Bio1_001090
Bio2_000111
Bio2_000591
Bonacid
BPBio1_000271
BRN 0497773
BSPBio_000245
BSPBio_001391
BSPBio_002071
C07266
C17H18N2O6
Calcibloc
Calcigard
Calcilat
Camont
Cardifen
Cardilat
Cardionorm
CAS-21829-25-4
CBiol_001826
CCRIS 6074
CHEBI:7565
CHEMBL193
Chronadalate
Chronadalate Lp
Chronadalate LP
CID4485
Citilat
cMAP_000042
Coracten
Coracten XL
Coral
Cordafen
Cordaflex
Cordalat
Cordicant
Cordilan
Cordipin
Cordipine
Corinfar
Corotrend
Corynphar
CPD000058291
D00437
D009543
DB01115
Depin
Dignokonstant
Dilafed
Dilcor
Dipinkor
DivK1c_000313
Duranifin
Ecodipi
Ecodipin
Ecodipin E
EINECS 244-598-3
Emaberin
EU-0100819
Fedcor
Fedcor Retard
Fenamon
Fenamon Sr
Fenamon SR
Fenigidin
Fenihidin
Fenihidine
Fortipine LA
Glopir
Hadipin
Hexadilat
HMS1361F13
HMS1568M07
HMS1791F13
HMS1920P19
HMS1989F13
HMS2051O03
HMS2089H11
HMS2091H20
|
HMS500P15
I06-0051
I06-1286
IDI1_000313
IDI1_033861
Infedipin
Introcar
KB-1712P
KBio1_000313
KBio2_000111
KBio2_001459
KBio2_002400
KBio2_002679
KBio2_004027
KBio2_004968
KBio2_005247
KBio2_006595
KBio2_007536
KBio3_000221
KBio3_000222
KBio3_001571
KBio3_002879
KBioGR_000111
KBioGR_000627
KBioGR_002400
KBioSS_000111
KBioSS_001459
KBioSS_002405
Kordafen
Korinfar
KRKA brand OF nifedipine
KRKA Brand of Nifedipine
L001054
Lopac0_000819
Lopac-N-7634
LS-1012
Macorel
Megalat
MLS000028521
MLS000758222
MLS001148146
MLS001401371
MolPort-000-787-707
MolPort-006-822-492
Monohydrochloride, nifedipine
Monohydrochloride, Nifedipine
Myogard
N 7634
N0528
N1fedilat
N7634_SIGMA
NCGC00015748-01
NCGC00015748-02
NCGC00015748-03
NCGC00015748-06
NCGC00015748-13
NCGC00024983-01
NCGC00024983-02
NCGC00024983-03
NCGC00024983-04
NCGC00024983-05
NCGC00024983-06
NCGC00024983-07
NCGC00024983-08
NCGC00091707-01
nchembio.95-comp13
Nedipin
Nicardia
Nifangin
Nifar
Nifdemin
Nifebene
Nifecard
Nifecor
Nifedepat
Nifediac
Nifedical
Nifedical XL
Nifedicor
Nifedin
Nifedine
nifedipine
Nifedipine
Nifedipine (JP15/USP/INN)
Nifedipine [USAN:BAN:INN:JAN]
Nifedipine bayer brand
Nifedipine Bayer Brand
Nifedipine gtis
Nifedipine GTIS
Nifedipine krka brand
Nifedipine KRKA Brand
Nifedipine monohydrochloride
Nifedipine Monohydrochloride
Nifedipine orion brand
Nifedipine Orion Brand
Nifedipine pfizer brand
Nifedipine Pfizer Brand
Nifedipine Retard
Nifedipine-gtis
Nifedipine-GTIS
Nifedipino
Nifedipino [INN-Spanish]
Nifedipinum
Nifedipinum [INN-Latin]
Nifedipres
Nifedirex LP
Nifelan
Nifelat
Nifelat Q
Nifelate
Nifensar XL
Nificard
Nifidine
Nifipen
NINDS_000313
Niphedipine
Oprea1_788617
Orion brand OF nifedipine
Orion Brand of Nifedipine
Orix
Oxcord
Pfizer brand OF nifedipine
Pfizer Brand of Nifedipine
Pidilat
Prestwick_357
Prestwick0_000063
Prestwick1_000063
Prestwick2_000063
Prestwick3_000063
Procardia
Procardia (TN)
Procardia XL
S1808_Selleck
SAM001246963
Sepamit
Slofedipine XL
SMR000058291
SPBio_001016
SPBio_002166
Spectrum_000979
SPECTRUM1500431
Spectrum2_001058
Spectrum3_000516
Spectrum4_000074
Spectrum5_001278
STK735567
Tensipine MR
Tibricol
Tocris-1075
UNII-I9ZF7L6G2L
Vascard
Zenusin
ZINC19594578
|
|
35 |
|
Cefotaxime |
Approved |
Phase 4 |
|
63527-52-6 |
456256 5742673 |
Synonyms:
(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R,Z)-3-(acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
60846-21-1
63527-52-6
63527-53-7
64485-93-4 (mono-hydrochloride salt)
AC1L1E42
AC1L9UKL
AC1NSF5T
AC1NSF6T
AC1NUIF8
AC1NX3QV
AC1NZU9Q
AC1O712I
AC1O7G8N
AC1OC9NB
AC-217
AKOS003286450
Aventis brand OF cefotaxime sodium
Aventis pharma brand OF cefotaxime sodium
Benaxima
BIDD:GT0681
Biosint
BPBio1_000240
BRD-K78364995-236-03-5
BRD-K99586414-236-02-3
BSPBio_000218
BSPBio_001961
C06885
C16H17N5O7S2
CE3
Cefotaxim
Cefotaxim hikma
Cefotaxim Hikma
Cefotaxim Hikma (TN)
Cefotaxima
Cefotaxima [INN-Spanish]
cefotaxime
Cefotaxime
Céfotaxime
Cefotaxime (INN)
Cefotaxime [INN:BAN]
Cefotaxime acid
Cefotaxime sodium
Cefotaximum
Cefotaximum [INN-Latin]
Cefradil
Cephotaxim
Cephotaxime
CHEBI:204928
CHEMBL102
CID2632
CID456256
CID5361298
CID5361354
|
CID5479527
CID5742673
CID5916965
CID6540461
CID6604086
CID6914272
CID7566336
CID9868614
Claforan
Claforan (*Sodium salt*)
CTX
D07647
DB00493
DivK1c_000767
EINECS 264-299-1
Fotexina
Fustery brand OF cefotaxime sodium
Galen brand OF cefotaxime sodium
HMS2090M11
Hoechst brand OF cefotaxime sodium
IDI1_000767
KBio1_000767
KBio2_000548
KBio2_003116
KBio2_005684
KBio3_001181
KBioGR_000736
KBioSS_000548
Kendrick
Klaforan
Liomont brand OF cefotaxime sodium
Lopac0_000278
LS-149920
LS-187246
Merck brand OF cefotaxime sodium
MolPort-002-339-742
MolPort-005-934-578
MolPort-006-834-754
NCGC00021126-01
NINDS_000767
Pisa brand OF cefotaxime sodium
Prestwick0_000139
Prestwick1_000139
Prestwick2_000139
Prestwick3_000139
Primafen
RU 24662
Ru-24756
Sodium, cefotaxime
SPBio_000138
SPBio_002157
Spectrum_000108
Spectrum2_000119
Spectrum3_000331
Spectrum4_000268
Spectrum5_000667
STK383264
Taporin
UNII-N2GI8B1GK7
Viken brand OF cefotaxime sodium
|
|
36 |
|
Netilmicin |
Approved, Investigational |
Phase 4 |
|
56391-56-1 |
441306 6857423 |
Synonyms:
(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
(2R,3S,4S,5S)-2-[(1S,2R,3S,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
1-N-Aethylsisomicin
1-N-Ethylsisomicin
2-[4-amino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
4-amino-3-{[3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-6-(ethylamino)-2-hydroxycyclohexyl 3-deoxy-4-c-methyl-3-(methylamino)pentopyranoside
56391-56-1
56391-57-2 (sulfate (2:5) salt)
AB00514048
AC-13442
AC1L1I7S
AC1L26N7
AC1L9AXV
AC1O7GGT
AC1Q57VA
AC1Q59OC
AR-1G0648
BPBio1_001324
BRN 5316582
BSPBio_001202
C07657
C21H41N5O7
CAS-56931-57-2
CHEMBL1572
CID10480069
CID41859
CID441306
CID4460
CID6604416
D08268
EINECS 260-146-8
HSDB 3584
|
LS-147005
MolPort-003-849-357
NCGC00016881-01
NCGC00179265-01
netilmicin
Netilmicin (INN)
Netilmicin [INN:BAN]
NETILMICIN SULFATE
Netilmicina
Netilmicina [INN-Spanish]
Netilmicine
Netilmicine [INN-French]
Netilmicinum
Netilmicinum [INN-Latin]
Netilmycin
Netilyn
Netira
Netira (TN)
Nettacin
NTL
O-(2,6-Diamino-2,3,4,6-tetradesoxy-alpha-glycero-4-hexenopyranosyl-(1-4)-O-(3-desoxy-4-C-methyl-3-methylamino-beta-L-arabinopyranosyl-(1-6)-2-desoxy-N1-ethyl-D-streptamin
O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-N(1)-ethyl-D-streptamine
O-3-Deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-a-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-N(1)-ethyl-D-streptamine
O-3-Deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-α-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-N(1)-ethyl-D-streptamine
Prestwick0_001101
Prestwick1_001101
Prestwick2_001101
Prestwick3_001101
Sch 20569
Sch-20569
SPBio_003081
UNII-4O5J85GJJB
Vectacin
|
|
37 |
|
Dibekacin |
Approved |
Phase 4 |
|
34493-98-6 |
|
Synonyms:
|
38 |
|
Heparin |
Approved, Investigational |
Phase 4 |
|
9005-49-6 |
772 9812414 |
Synonyms:
101921-26-0
102785-31-9
102-94-3
104521-37-1
11078-24-3
11129-39-8
12656-11-0
37324-73-5
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
Allocinnamic acid
alpha-Heparin
Alpha-Heparin
Ardeparin
Ardeparin sodium
Ariven
Arteven
Bemiparin
Bemiparin sodium
Calcilean
Calciparine
Certoparin
CID8784
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
Clexane
Clivarin
Clivarine
CY 216
Cy 222
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
Enoxaparin
Enoxaparin sodium
Eparina
Eparina [DCIT]
Fluxum
FR 860
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
Hed-heparin
Hed-Heparin
Hep Flush Kit in plastic container
Hepalean
heparin
Heparin Cy 216
Heparin CY 216
Heparin Leo
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
Heparin sodium 25,000 units in dextrose 5%
|
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sodium salt
Heparin sulfate
Heparin sulphate
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Hep-Lock
Hep-Lock U/P
HSDB 3094
Innohep
Inno-Hep
Isocinnamic acid
Kabi 2165
KB 101
Leparan
LHN 1
Lioton 1000
Lipo-hepin
Lipo-Hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Low molecular weight heparin sodium
Minolteparin sodium
MolPort-003-760-257
Multiparin
Nadroparin
Nadroparine
Novoheparin
NSC174025
Octaparin
OP 386
OP 622
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
Unfractionated heparin
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Vetren
Vitrum AB
WY 90493RD
|
|
39 |
|
Phenprocoumon |
Approved, Investigational |
Phase 4 |
|
435-97-2 |
9908 54680692 |
Synonyms:
2-hydroxy-3-(1-phenylpropyl)chromen-4-one
3-(1-Phenylpropyl)-4-hydroxycoumarin
3-(1'-Phenyl-propyl)-4-oxycoumarin
3-(1'-Phenyl-propyl)-4-oxycoumarin [German]
3-(a-Ethylbenzyl)-4-hydroxycoumarin
3-(alpha-Ethylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenylpropyl)-4-hydroxycoumarin
3-(a-Phenylpropyl)-4-hydroxycoumarin
3-(Α-ethylbenzyl)-4-hydroxycoumarin
3-(Α-phenylpropyl)-4-hydroxycoumarin
435-97-2
4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one
4-hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one
4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one
AC1L1U3E
AKOS002126557
BRN 1291115
CHEBI:117471
CHEBI:50438
CHEMBL1465
CHEMBL16694
CID9908
D010644
D05457
DB00946
EINECS 207-108-9
Falithiom
Falithrom
Fencumar
Fenprocoumona
Fenprocoumona [INN-Spanish]
fenprocumon
Fenprocumon
Fenprocumone
Fenprocumone [DCIT]
|
Hexal brand OF phenprocoumon
Hexal Brand of Phenprocoumon
HSDB 3248
Liquamar
Liquamar (TN)
LS-55203
Marcoumar
Marcumar
Marcuphen
MolPort-005-935-554
Oprea1_002598
Phenprocoumalol
Phenprocoumarol
Phenprocoumarole
Phenprocoumon
PHENPROCOUMON
Phenprocoumon (USAN/INN)
Phenprocoumon [USAN:INN:BAN]
Phenprocoumone
Phenprocoumone [INN-French]
Phenprocoumonum
Phenprocoumonum [INN-Latin]
Phenprocumone
Phenprocumonum
Phenprogramma
Phenylpropylhydroxycumarinum
Ro 1-4849
Roche brand OF phenprocoumon
Roche Brand of Phenprocoumon
S2188_Selleck
U29342
UNII-Q08SIO485D
Worwag Brand of Phenprocoumon
Wörwag brand OF phenprocoumon
|
|
40 |
|
Insulin glulisine |
Approved |
Phase 4 |
|
207748-29-6 |
|
Synonyms:
Insulin glulisine
Insulin Glulisine (recombinant DNA origin)
|
Insulin glulisine recombinant
Insulina glulisina
|
|
41 |
|
Argatroban |
Approved, Investigational |
Phase 4 |
|
74863-84-6 |
152951 |
Synonyms:
(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid
(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(3R)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid
(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid
(2R,4R)-1-[5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid
(2R,4R)-4-Methyl-1-((S)-N(sup 2)-(((RS)-1,2,3,4-tetrahydro-3-methyl-8-quinolyl)sulfonyl)arginyl)pipecolic acid
(2r,4r)-4-methyl-1-[n2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-l-arginyl]-2-piperidinecarboxylic acid
(2R,4R)-4-Methyl-1[Nalpha-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl)]-2-piperadinecarboxylic acid
121785-71-5
1dwc
21R-Argatroban
4-methyl-1-(N(2)-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl)-2-piperidinecarboxylic acid
4-Methyl-1-(N(2)-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl)-2-piperidinecarboxylic acid
74863-84-6
82784-65-4
AC-15185
AC1L3OPA
AC1L49F4
AC1L99H9
AC1L9HII
AC1Q5QXC
Acova
AR-1A3021
argatroban
Argatroban
Argatroban (anhydrous)
Argatroban [INN:JAN]
Argatroban anhydrous
Argatrobanum
Argatrobanum [Latin]
BIDD:GT0748
C04931
C23H36N6O5S
CHEBI:194249
CHEBI:288815
|
CHEMBL1166
CHEMBL59461
CID152951
CID440542
CID445156
CID92722
CPD000466348
DB00278
GN-1600
HMS2051N07
HMS2090L12
KST-1A8419
LS-114621
LS-114640
MCI 9038
MCI-9038
MD 805
MD805
MD-805
MITSUBISHI INHIBITOR
MLS000759461
MLS001424093
MMTQAP
MolPort-003-987-205
MPQA
MQI-ARG-MCP
NCGC00164592-01
NCGC00166413-01
Novastan
SAM001246661
SMR000466348
TL8005144
UNII-OCY3U280Y3
|
|
42 |
|
Donepezil |
Approved |
Phase 4 |
|
120014-06-4 |
3152 |
Synonyms:
( inverted exclamation markA)-E 2020
120014-06-4
1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC1L1FAE
AC-6969
AKOS000277311
Aricept
Aricept odt
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
|
Donepezil
Donepezil (INN)
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilium oxalate trihydrate
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum_001664
Spectrum5_001662
TL8000531
UNII-8SSC91326P
|
|
43 |
|
Ranolazine |
Approved, Investigational |
Phase 4 |
|
95635-55-5, 142387-99-3 |
56959 |
Synonyms:
( -)-Ranolazine
(-)-Ranolazine
142387-99-3
95635-55-5
AC-1673
AC1L1M17
AC1Q5LYD
BRD-A97674275-001-01-9
BSPBio_002276
CHEMBL1404
CID56959
CVT-303
D05700
DB00243
Dihydrochloride, ranolazine
HCL, Ranolazine
HMS1922F16
HMS2090L09
HMS2093D21
Hydrochloride, ranolazine
I01-2008
I06-0160
KEG-1295
Latixa
Lopac0_001062
LS-187267
MLS002154149
MolPort-003-666-653
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
|
N-(2,6-Dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide
NCGC00015897-05
NCGC00095177-01
NCGC00095177-02
NCGC00095177-03
RAN D
Ran4
Ranexa
Ranexa (TN)
Ranexa, Ranolazine
Ranolazina
ranolazine
Ranolazine
RANOLAZINE
Ranolazine (USAN/INN)
Ranolazine 2HCl
Ranolazine 2HCL
Ranolazine dihydrochloride
Ranolazine Dihydrochloride
Ranolazine HCL
Ranolazine hydrochloride
Renolazine
RS-43285
RS-43285-003
S1799_Selleck
SMR000857382
SPECTRUM1505366
UNII-A6IEZ5M406
|
|
44 |
|
Oseltamivir |
Approved |
Phase 4 |
|
196618-13-0, 204255-11-8 |
65028 |
Synonyms:
(-)-oseltamivir
(−)-oseltamivir
(-)-Oseltamivir
(3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid
(3R,4R,5S)-4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid
196618-13-0
204255-11-8
4-Acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid
AC1L22FK
AC1Q63H0
Agucort
Agucort (TN)
BIDD:GT0426
BRD-K76011241-045-01-5
C08092
CHEBI:7798
CHEMBL1229
CID65028
D08306
DB00198
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate
Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate
|
FT-0082384
GS 4104
GS4104
GS-4104
HMS2090C11
HSDB 7433
LS-57422
MolPort-005-933-026
NCGC00178698-01
oseltamivir
Oseltamivir
Oséltamivir
Oseltamivir (INN)
Oseltamivir [INN:BAN]
Oseltamivir phosphate
oseltamivirum
Oseltamivirum
Ro-640796
Ro-64-0796
Tamiflu
Tamiflu (*Phosphate salt 1:1*)
Tamiflu-Free
Tamvir
UNII-20O93L6F9H
|
|
45 |
|
Theophylline |
Approved |
Phase 4 |
|
58-55-9 |
2153 |
Synonyms:
1,3 Dimethylxanthine
1,3-dimethyl-7H-purine-2,6-dione
1,3-Dimethyl-7H-purine-2,6-dione
1,3-dimethylxanthine
1,3-Dimethylxanthine
111079-49-3
1H-purine-2,6-dione
2a3a
3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione
46157-00-0
56645-32-0
58-55-9
75448-53-2
AB00052106
AC1L1D1F
AC-20328
Accurbron
Acet-theocin
Aerobin
Aerolate
Aerolate III
Aerolate SR
Afonilm
Afonilum
Afonilum retard
Afonilum Retard
AI3-50216
AKOS000120961
aminophylline
Aminophylline
Anhydrous, theophylline
Aquaphyllin
Armophylline
Asbron
Asmalix
Asmax
Austyn
BCBcMAP01_000071
BIDD:ER0557
BIDD:GT0151
Bilordyl
BPBio1_000791
BPBio1_001041
Bronchodid Duracap
Bronchoparat
Bronchoretard
Bronkodyl
Bronkodyl SR
Bronkotabs
BSPBio_000719
BSPBio_000945
BSPBio_002363
C07130
C7H8N4O2
CCRIS 4729
Cetraphylline
CHEBI:28177
CHEMBL190
Choledyl sa
Choledyl SA
Chronophyllin
CID2153
Constant T
ConstantT
Constant-T
CPD000058537
CPD-12479
CT Arzneimittel brand OF theophylline sodium glycinate
ct, theo von
CT, Theo von
CT-Arzneimittel brand OF theophylline sodium glycinate
D00371
D013806
DB00277
Diffumal
Dimethylxanthine
Diphyllin
DivK1c_000203
Doraphyllin
Duraphyl
Duraphyllin
Dyspne-inhal
Egifilin
EINECS 200-385-7
Elixex
Elixicon
Elixomin
Elixophyllin
Elixophyllin (TN)
Elixophyllin SR
Elixophyllin(e)
Elixophylline
Etheophyl
Euphylline
Euphylong
Fameasan brand OF theophylline sodium glycinate
Fujisawa brand OF theophylline sodium glycinate
Glycinate, theophylline sodium
Glycine theophyllinate
GS 2591A
HMS1921E03
HMS2089A06
HMS2092M05
HMS500K05
HSDB 3399
Hylate
IDI1_000203
KBio1_000203
KBio2_001518
KBio2_004086
KBio2_006654
KBio3_001583
KBioGR_000785
KBioSS_001518
L000595
Labid
LaBID
Labophylline
Lanophyllin
LASMA
Liquophylline
Liquorice
Lodrane
Lopac0_000014
LS-241
Maphylline
Medaphyllin
MLS000069390
MLS002152943
MLS002153487
MolPort-001-002-058
MolPort-001-737-342
Monospan
Mudrane
Mundipharma brand OF theophylline sodium glycinate
NCGC00018117-01
NCGC00018117-16
NCGC00022112-03
NCGC00022112-04
NCGC00022112-05
NCGC00022112-07
NCGC00022112-08
NCGC00022112-09
NCGC00022112-10
NCGC00022112-11
nchembio.273-comp2
NCI60_001736
NINDS_000203
NSC 2066
NSC2066
Nuelin
Nuelin S.A
Nuelin s.a.
Nuelin S.A.
Nuelin SA
Optiphyllin
Parkophyllin
PDSP1_001018
PDSP1_001234
PDSP2_001002
PDSP2_001218
Physpan
Prestwick0_000820
Prestwick0_000873
Prestwick1_000820
Prestwick1_000873
Prestwick2_000820
|
Prestwick2_000873
Prestwick3_000820
Prestwick3_000873
Pro-vent
Pseudotheophylline
Pulmidur
Pulmo-Timelets
Quibron
Quibron T
Quibron T SR
Quibron t/sr
Quibron T/SR
Quibron TSR
Quibron T-SR
Quibron-t
Quibron-T
Quibron-t (TN)
Quibron-t/sr
Quibron-T/SR
Respbid
Respicur
Respid
S1621_Selleck
SAM002554935
Slo phyllin
Slo Phyllin
Slo-bid
Slo-phyllin
SloPhyllin
SMP1_000291
SMR000058537
Sodium glycinate, theophylline
Solosin
Somophyllin CRT
Somophyllin T
Somophyllin-CRT
Somophyllin-DF
Somophyllin-t
SomophyllinT
Somophyllin-T
SPBio_000823
SPBio_002640
SPBio_002866
Spectrum_001038
SPECTRUM1500568
Spectrum2_000842
Spectrum3_000672
Spectrum4_000353
Spectrum5_001232
Spophyllin retard
ST024762
STK397040
Sustaire
Synophylate
Synophylate-l.a. cenules
T0179
T1633_SIGMA
T4924_SIGMA
T7770_SIGMA
T9031_SIGMA
Talotren
Tefamin
Telbans Dry Syrup
Telb-DS
Teocen 200
Teofilina
Teofilina [Polish]
Teofyllamin
Teolair
Teonova
Teosona
Tesona
Theacitin
Theal tabl.
Theal tablets
Theo 24
Theo dur
Theo Dur
theo von ct
Theo von CT
Theo-11
Theo24
Theo-24
Theo-24 (TN)
Theobid
Theobid Duracap
THEOBID JR
Theobid jr.
Theobid Jr.
Theochron
Theocin
Theoclair-SR
Theoclear
Theoclear 80
Theoclear l.a.-130
Theoclear L.A.-130
Theoclear la
Theoclear LA
Theoclear-200
Theoclear-80
Theoconfin continuous
Theocontin
Theodel
Theodrip
Theo-DS
Theodur
Theo-dur
Theodur Dry Syrup
Theodur g
Theodur G
Theodur G (TN)
Theo-dur-sprinkle
Theo-Dur-Sprinkle
Theofol
Theograd
Theokin
Theolair
Theolair (TN)
Theolair-SR
Theolix
Theolixir
Theon
Theona p
Theona P
Theonite
Theo-Nite
Theo-Organidin
Theopek
Theophyl
Theophyl-225
Theophyline
Theophyllin
Theophyllinate, glycine
theophylline
Theophylline (JP15)
Theophylline anhydrous
Theophylline sodium glycinate
Theophylline, anhydrous
Theophylline-[8-3H
Theophylline-SR
Theophyl-SR
Theoplus
Theo-Sav
Theospan
Theostat
Theostat 80
Theotard
Theovent
T-Phyl
Uni-dur
Uni-Dur
Unifyl
UNII-0I55128JYK
Unilong
Uniphyl
Uniphyl (TN)
Uniphyllin
Uniphyllin continus
Uniphylline
UPCMLD-DP123
UPCMLD-DP123:001
von ct, theo
Von CT, theo
X 115
Xanthium
Xantivent
ZINC18043251
|
|
46 |
|
Lamivudine |
Approved, Investigational |
Phase 4 |
|
134678-17-4 |
60825 |
Synonyms:
(-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-2'-Deoxy-3'-thiacytidine
(-)-BCH 189
(-)-BCH-189
(-)-beta-L-2',3'-Dideoxy-3'-thiacytidine
(-)NGPB-21
(-)-SddC
(+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(+/-)-3TC
(+/-)-BCH-189
(+/-)-SddC
(2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
.beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
134678-17-4
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis)
2',3' Dideoxy 3' thiacytidine
2',3'-Dideoxy-3'-thiacytidine
3TC
3TC & GNA
3TC & SST
3TC (AIDS INITIATIVE) (AIDS INITIATIVE)
3TC and NV-01
3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine
3'-Thia-2',3'-dideoxycytidine
480434-79-5
4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
AC-1416
AC1L1TZZ
AC1Q6C34
BCH 189
BCH189
BCH-189
BCH-790
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
BIDD:GT0033
Bio-0652
b-L-2',3'-Dideoxy-3'-thiacytidine
b-L-3'-Thia-2',3'-dideoxycytidine
C07065
C8H11N3O3S
CCRIS 9274
CHEBI:133986
CHEMBL141
CID60825
CPD000466319
D00353
D019259
|
DB00709
DRG-0126
DTHC
Epivir
Epivir (TN)
Epivir(TM)
Epivir-HBV
Epzicom
FT-0082667
GG-714
GR 109714X
GR109714X
GR-109714X
Hepitec
Heptivir
Heptodin
Heptovir
HHA & 3TC
HHA & Lamivudine
HMS2051D21
HSDB 7155
L0217
Lamivir
Lamivudin
Lamivudina
lamivudine
Lamivudine
Lamivudine & GNA
Lamivudine (JAN/USP/INN)
Lamivudine [Usan:Ban:Inn]
Lamivudine [USAN:BAN:INN]
Lamivudine [USAN:INN:BAN]
Lamivudine, (2S-cis)-isomer
Lamivudine, (2S-cis)-Isomer
Lamivudinum
LMV
LS-2107
MLS000759424
MLS001424097
MolPort-002-507-347
NCGC00159341-03
NCGC00159341-04
NSC620753
S1706_Selleck
SAM001246582
SAM002589994
SMR000466319
STK801940
UNII-2T8Q726O95
Zeffix
Zefix
ZINC00012346
Β-L-2',3'-dideoxy-3'-thiacytidine
Β-L-3'-thia-2',3'-dideoxycytidine
|
|
47 |
|
Peginterferon alfa-2a |
Approved, Investigational |
Phase 4 |
|
198153-51-4 |
5360545 |
Synonyms:
198153-51-4
D02747
Pegasys
Pegasys (TN)
PEG-IFN alfa-2A
Peginterferon alfa-2a
PEG-Interferon alfa-2A
|
Peginterferon alfa-2a (genetical recombination)
Peginterferon alfa-2a (genetical recombination) (JAN)
Peginterferon alfa-2a (USAN/INN)
Pegylated Interfeaon alfa-2A
Pegylated interferon alfa-2a
Pegylated interferon alpha-2a
Pegylated-interferon alfa 2a
|
|
48 |
|
Liraglutide |
Approved |
Phase 4 |
|
204656-20-2 |
44147092 |
Synonyms:
204656-20-2
Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
C439759
Liraglutida
Liraglutida [INN-Spanish]
Liraglutide
Liraglutide (genetical recombination)
Liraglutide (rDNA origin)
Liraglutide [USAN:INN]
Liraglutide recombinant
Liraglutidum
Liraglutidum [INN-Latin]
|
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide
N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
N²⁶-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide
N²⁶-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide
nn 2211
NN 2211
nn2211
NN2211
NN-2211
UNII-839I73S42A
victoza
Victoza
|
|
49 |
|
Lixisenatide |
Approved |
Phase 4 |
|
320367-13-3 |
|
Synonyms:
des-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-L-lysyl-L-lysinamide
DesPro38Exendin-4(1-39)-Lys6-NH2
Lixisenatida
|
Lixisenatide
Lixisénatide
|
|
50 |
|
Iodine |
Approved, Investigational |
Phase 4 |
|
7553-56-2 |
807 |
Synonyms:
Cadex
diiodine
Diiodine
I2
Iode
Iodine
Iodine 127
Iodine-127
Iodine-molecule
|
Iodio
iodo
Iodum
Jod
Jood
molecular iodine
Molecular iodine
Tincture iodine
|
|
Interventional clinical trials:
(show top 50)
(show all 4893)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Phase 4 Study of Medical Therapy Versus Medical Therapy Plus Renal Artery Stenting in Preventing the Progression of Renal Failure in Atherosclerotic Renovascular Disease |
Unknown status |
NCT01023373 |
Phase 4 |
Medical treatment |
2 |
NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED |
Unknown status |
NCT00501475 |
Phase 4 |
NAC Bicarbonate |
3 |
The Effects of Thiazolidinedione on the Diabetic Retinopathy and Nephropathy |
Unknown status |
NCT01175486 |
Phase 4 |
Actos (Pioglitazone);Acarbose |
4 |
Phase 4 Study of Alprostadil Prevent Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization |
Unknown status |
NCT01722513 |
Phase 4 |
Alprostadil ﹠control |
5 |
Renoprotection by Combining Pentoxifylline and Angiotensin Blockade in Chronic Kidney Disease |
Unknown status |
NCT01377285 |
Phase 4 |
ARB;Pentoxifylline;Placebo (for Pentoxifylline) |
6 |
Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure |
Unknown status |
NCT00716001 |
Phase 4 |
N-acetylcysteine |
7 |
A Prospective Randomized, Double-Blind Parallel Group Trial To Assess The Efficacy And Safety Of Intravenous Dextrose 5% Solution Compare With Normal Saline (Standard Care) In Rinsing During Haemodialysis In Subjects With End Stage Renal Failure (ESRF) With Respect To Systolic Blood Pressure Control Over 3 Months Period. |
Unknown status |
NCT02590081 |
Phase 4 |
Dextrose 5%;normal saline |
8 |
Evaluation of Nail Fold Microcirculation and Interventional Therapy in Patients With Chronic Renal Failure |
Unknown status |
NCT03682952 |
Phase 4 |
Alprostadil Injection;Beraprost sodium tablets |
9 |
A comParison on Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Study Among SeVerE Chronic Kidney Disease/ End-Stage-Renal-Disease Patients With Recent Acute Coronary Syndrome. |
Unknown status |
NCT02459288 |
Phase 4 |
Clopidogrel first;Ticagrelor first |
10 |
Reduction or Discontinuation of Calcineurine Inhibitors With Conversion to Everolimus-Based Immunosuppresion to Alleviate Chronic Allograft Nephropathy (CAN) in Kidney Transplant Recipients: A Prospective Randomized Study |
Unknown status |
NCT00443508 |
Phase 4 |
adding Certican to therapy;reducing Tacrolimus |
11 |
Periprocedural Administration of Folic Acid for Prevention of Contrast Induced Nephropathy in Patients Undergoing Coronary CTA/Angiography/Angioplasty |
Unknown status |
NCT02444013 |
Phase 4 |
Folic acid;Placebo |
12 |
Phase 4 Study of Sarpogrelate That Prevent Contrast-induced Nephropathy |
Unknown status |
NCT01165567 |
Phase 4 |
sarpogrelate |
13 |
Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease |
Unknown status |
NCT00204256 |
Phase 4 |
Iron sucrose |
14 |
The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease |
Unknown status |
NCT01157260 |
Phase 4 |
Kremezin |
15 |
Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease: An Interventional and Methodological Study |
Unknown status |
NCT00235287 |
Phase 4 |
Candesartan and enalapril;candesartan and enalapril;candesartan and enalapril;candesartan and enalapril |
16 |
Effects of Cholecalciferol on Osteoprotegerin Levels and Other Clinical Outcomes in Chronic Kidney Disease Patients on Peritoneal Dialysis: a Randomized Controlled Trial |
Unknown status |
NCT02598635 |
Phase 4 |
Cholecalciferol;Placebo |
17 |
Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease: a Randomized Clinical Trial |
Unknown status |
NCT01155128 |
Phase 4 |
|
18 |
A Randomized Prospective Trial of N-acetyl Cystein in Patients With Peritoneal Dialysis |
Unknown status |
NCT01111422 |
Phase 4 |
N-acetylcysteine |
19 |
Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis |
Unknown status |
NCT02338635 |
Phase 4 |
Ursodeoxycholic Acid |
20 |
the Effect of Calcium Dobesilate on Non Dialysis Patients With Chronic Renal Failure |
Unknown status |
NCT03427944 |
Phase 4 |
Calcium Dobesilate group;Conventional Treatment group |
21 |
Canadian Collaborative Group for the Prevention of Illness in Chronic Renal Disease. The Canadian Prevention of Renal and Cardiovascular Endpoints Trial |
Unknown status |
NCT00231803 |
Phase 4 |
|
22 |
The Effect of Far Infrared (FIR) Therapy on Access Flow of Arteriovenous (AV) Fistula, Echocardiographic Parameters and Endothelial Function in Patients With End Stage Renal Disease |
Unknown status |
NCT01138254 |
Phase 4 |
|
23 |
Effects of Non-Glucose-Based Peritoneal Dialysis Solution "EXTRANEAL" on Changes in Leptin Levels and Sympathetic Activity Induced by Conventional Glucose-Based Dialysate "DIANEAL" in Patients on Peritoneal Dialysis |
Unknown status |
NCT01228279 |
Phase 4 |
|
24 |
Study on the Effect of Hyperuricaemia on Chronic Renal Disease and Intervention |
Unknown status |
NCT03425708 |
Phase 4 |
20mg Febuxostat;40mg Febuxostat |
25 |
Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease |
Unknown status |
NCT00852787 |
Phase 4 |
Digoxin immune fab;Placebo |
26 |
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Nephropathy |
Unknown status |
NCT01094769 |
Phase 4 |
Moxonidine;Placebo |
27 |
Effect of Intravenous and Oral Therapy With Sulodexide on Albuminuria in Type 2 Diabetic Patients |
Unknown status |
NCT01316068 |
Phase 4 |
intravenous use of sulodexide followed by oral use;use of sulodexide orally only |
28 |
Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes |
Unknown status |
NCT01869881 |
Phase 4 |
Anplag(Sarpogrelate);Placebo |
29 |
Phase 4 Study of Mechanisms of Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy |
Unknown status |
NCT01300273 |
Phase 4 |
|
30 |
Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy |
Unknown status |
NCT01673204 |
Phase 4 |
Calcitriol;Placebo |
31 |
Effect of Aldosterone Antagonism in the Reduction of Albuminuria and Diastolic Disfunction of Patients With Diabetic Nephropathy. |
Unknown status |
NCT00870402 |
Phase 4 |
Spironolactone;Placebo |
32 |
Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP |
Unknown status |
NCT00584350 |
Phase 4 |
|
33 |
Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function: A Prospective Randomised Controlled Trial |
Unknown status |
NCT00541814 |
Phase 4 |
Cyclosporine |
34 |
A Randomized, Prospective, Open-Label Study of Rituximab in the Treatment of Recurrent IgA Nephropathy With Active Endocapillary Proliferation Pathology |
Unknown status |
NCT02571842 |
Phase 4 |
Intravenous Rituximab;ACEI/ARB and corticosteroids |
35 |
Preventive Effect of the PRetreatment With pItavastatiN on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndErgoing Coronary Angiography/Intervention (PRINCIPLE-II Study) |
Unknown status |
NCT01871792 |
Phase 4 |
Pitavastatin;Placebo |
36 |
Safety of Add on Aliskiren to ACEI and ARB Treatment in Type 2 Diabetes With Nephropathy |
Unknown status |
NCT00949351 |
Phase 4 |
Aliskiren 300mg/d |
37 |
A Prospective Randomized, Controlled, Open-labeled Trial of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy |
Unknown status |
NCT01758120 |
Phase 4 |
prednisone plus cyclophosphamide;Prednisone alone |
38 |
Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy:a Single Center Prospective Randomized Controlled Study |
Unknown status |
NCT02765594 |
Phase 4 |
Hydroxychloroquine Sulfate;Valsartan |
39 |
Preventive Strategies of REnal Insufficiency in Patients With Diabetes Undergoing InterVENTion or Arteriography(PREVENT Trial) |
Unknown status |
NCT00950079 |
Phase 4 |
Sodium bicarbonate;saline |
40 |
Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy: a Multicentre, Double-blind, Double-dummy, Randomized Controlled Trial |
Unknown status |
NCT02231125 |
Phase 4 |
Losartan;Abelmoschus manihot |
41 |
Multi-center, Randomized, Open Label, Comparative, Phase IV Study to Evaluate the Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid for 48 Weeks in Advanced IgA Nephropathy |
Unknown status |
NCT02981212 |
Phase 4 |
Mycophenolate Mofetil;ACE inhibitor;Corticosteroid;ARB |
42 |
A Prospective Randomized, Controlled Trial of Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy |
Unknown status |
NCT03170323 |
Phase 4 |
Mycophenolate Mofetil;Cyclosporins |
43 |
N-Acetylcysteine to Prevent Contrast-Induced Nephropathy in Acute Coronary Syndromes |
Unknown status |
NCT00939913 |
Phase 4 |
intravenous NAC;Placebo |
44 |
A Prospective, Randomized, Two Period, With an Intermediate Wash Out Period, Cross-over Study to Compare the Effects of Either Combined Therapy With Ramipril and Clopidogrel or Ramipril Monotherapy on Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Patients With Type 2 Diabetes and Diabetic Nephropathy |
Unknown status |
NCT01743014 |
Phase 4 |
Ramipril;Clopidogrel |
45 |
Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension |
Unknown status |
NCT00407680 |
Phase 4 |
Intensive therapy Valsartan,Fluvastatin |
46 |
Neutrophil gElatinase-associated Lipocalin alloWs Intensive treatMent Of cOntrast Induced Nephropathy in Patients With Urgent/Emergency Percutaneous Coronary Intervention |
Unknown status |
NCT01491243 |
Phase 4 |
Intensive treatment with sodium bicarbonate;Standard treatment with saline infusion |
47 |
The Metabolic and Anti-Inflammatory Effects of Combined Ezetimibe and Simvastin Therapy, as Compared to Simvastatin Alone, in Patients With Chronic Proteinuric Nephropathy |
Unknown status |
NCT00861731 |
Phase 4 |
simvastatin;EZE/simvastatin;EZE/simvastatin |
48 |
Preventing Contrast Induced Nephropathy After Transcatheter Aortic Valve Replacement |
Unknown status |
NCT03121053 |
Phase 4 |
sodium bicarbonate;hypotone saline |
49 |
Prospective Trial of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients With Chronic Allograft Nephropathy |
Unknown status |
NCT00999258 |
Phase 4 |
sirolimus |
50 |
The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Chronic Kidney Diseases Patients With Persistent Proteinuria |
Unknown status |
NCT00858299 |
Phase 4 |
valsartan |
Inferred drug relations via
UMLS
71
/
NDF-RT
51
:
Albumin Human, USP
ALBUMIN,HUMAN INJ
|
Dopamine
Dopamine Hydrochloride
|
Cochrane evidence based reviews: kidney diseases
|